好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2011 Annual Meeting | Poster Session 03

Tuesday 04/12/11
02:00 PM - 06:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Cerebrovascular Disease and Interventional Neurology, History of Neurology, Movement Disorders, Neuro-oncology, Neuro-ophthalmology/Neuro-otology, Aging and Dementia, Anterior Horn, Behavioral Neurology, Clinical Neurophysiology, Epilepsy, Ethics, Pain and Palliative Care, Headache, Interventional Neurology, MS and Related Diseases, Neural Repair/Rehabilitation, Neurologic 好色先生, Neurotoxicology, Peripheral Nerve
No CME available
Event Timeline
02:00 PM - 06:30 PM Abstract 001 - Effect of Prior Exposure to Immediate Release (IR) Alpha 2 Delta Ligands on the Efficacy and Adverse Event Profile of Gabapentin Extended Release (ER) for the Treatment of Post Herpetic Neuralgia (PHN)
02:00 PM - 06:30 PM Abstract 002 - Effect of Adding Milnacipran to Pregabalin for the Management of Fibromyalgia: A Randomized, Open-Label, Controlled Study
02:00 PM - 06:30 PM Abstract 003 - Validation of Patient Reported Outcome (PRO) Endpoints for Nonsurgical Treatment of Lumbar Spinal Stenosis
02:00 PM - 06:30 PM Abstract 004 - Nortriptyline and Amitriptyline Are Equal in Treating Neuropathic Pain
02:00 PM - 06:30 PM Abstract 005 - Botulinum Toxin A for Treatment of Allodynia of Complex Regional Pain Syndrome: A Pilot Study
02:00 PM - 06:30 PM Abstract 006 - Effects of Milnacipran Added to Pregabalin on Cognition and Mental Clarity in Fibromyalgia Patients
02:00 PM - 06:30 PM Abstract 007 - Botulinum Toxin A (Botox) for Treatment of Proximal Myofascial Pain in Complex Regional Pain Syndrome: Two Cases
02:00 PM - 06:30 PM Abstract 008 - Charlatan Exploitation of Neurological Symptoms: The Case of the Reinhardt Brothers
02:00 PM - 06:30 PM Abstract 009 - Neurologists' Contributions to the Development of Performing Arts Medicine
02:00 PM - 06:30 PM Abstract 011 - Neurasthenia Due to World War I Chemical Warfare Agent Exposure: The Opinions of COL Edward Vedder, MC, USA
02:00 PM - 06:30 PM Abstract 012 - Le Grand Lobe Limbique: History and Evolution of Limbic System
02:00 PM - 06:30 PM Abstract 013 - Neurology in the Shadow of Nazi Germany
02:00 PM - 06:30 PM Abstract 014 - Neurologic Vitamin Deficiency Disorders during Wartime
02:00 PM - 06:30 PM Abstract 015 - Da Vinci and Myology: A Historical Perspective
02:00 PM - 06:30 PM Abstract 016 - The Knud Krabbe-Henry Alsop Riley Letters (1929-1959): Trans-Atlantic Friendship Fostered by the International Neurological Congresses
02:00 PM - 06:30 PM Abstract 017 - Parkinson's Disease Outlives Poskanzer's and Schwab's Erroneous Post-Flu Eradication Scenario
02:00 PM - 06:30 PM Abstract 018 - Lessons from War: What Gordon Holmes Learned from Gunshot Wounds to the Head
02:00 PM - 06:30 PM Abstract 019 - History of Neurology in Taiwan
02:00 PM - 06:30 PM Abstract 020 - Beyond Microglia and Oligodendroglia: The Legacy of Pio Del Rio Hortega to Neurological Science
02:00 PM - 06:30 PM Abstract 021 - Mercury Exposure in Ancient Peru: Lessons for a Changing Industrial World
02:00 PM - 06:30 PM Abstract 022 - Misfiring of the Little Gray Cells: A Review of Seizures in the Works of Agatha Christie
02:00 PM - 06:30 PM Abstract 023 - Greater Occipital Nerve Blocks for Treatment of Headache in the Acute Setting of Intracranial Hemorrhage
02:00 PM - 06:30 PM Abstract 024 - Percutaneous Retrogasserian Glycerol Rhizotomy for the Treatment of Trigeminal Neuralgia: Study of a Patient Population in Huntington, West Virginia
02:00 PM - 06:30 PM Abstract 025 - Transcatheter Patent Foreamen Ovale (PFO) Closure among Patients with Episodic (EM) and Chronic Migraine (CM)
02:00 PM - 06:30 PM Abstract 026 - Improvement in Headaches with CPAP for Obstructive Sleep Apnea
02:00 PM - 06:30 PM Abstract 028 - An Open-Label, 2-Period, Crossover Study Comparing the Pharmacokinetics and Tolerability of LEVADEX[trade] (MAP0004, Orally Inhaled DHE) and Intravenous DHE (DHE45[reg]) in Smoking and Non-Smoking Adult Volunteers
02:00 PM - 06:30 PM Abstract 029 - A Randomized, Double-Blind, Placebo Controlled, Three-Period Crossover Study Comparing the Acute Effects of LEVADEX[trade] (MAP0004, Orally Inhaled DHE) and Intravenous DHE on Pulmonary Arterial Systolic Pressure
02:00 PM - 06:30 PM Abstract 030 - DHE May Effectively Treat Opioid Induced Triptan Non-Responsive Headache
02:00 PM - 06:30 PM Abstract 032 - Olfactory Acuity in Migraine during and between Attacks: A Case-Control Study
02:00 PM - 06:30 PM Abstract 033 - Insulin Sensitivity Is Impaired in Chronic Migraine
02:00 PM - 06:30 PM Abstract 035 - Episodic Headache in North American Patients with Behcet's Disease
02:00 PM - 06:30 PM Abstract 036 - Clinical Characteristics of Primary Sudden Maximal Onset Headache
02:00 PM - 06:30 PM Abstract 037 - Acute Posterior Multifocal Placoid Pigment Epitheliopathy: Are "White Spots" Another "Red Flag" in Patients with Headache
02:00 PM - 06:30 PM Abstract 038 - Use of Transcranial Doppler To Identify Vascular Causes of Headache in Veterans
02:00 PM - 06:30 PM Abstract 039 - Infected Cervical Epidural Hematoma Presenting with Thunderclap Headache
02:00 PM - 06:30 PM Abstract 040 - Hyperperfusion Associated with Prolonged Aura in FHM with a Novel ATP1A2 Gene Mutation in Japan
02:00 PM - 06:30 PM Abstract 041 - Pattern of Migraine during Pregnancy and Postpartum Period in Japanese Patients
02:00 PM - 06:30 PM Abstract 042 - Chronic Cerebellar Hemorrhage in Spontaneous Intracranial Hypotension: Association with Anterior Spinal Cerebrospinal Fluid Leaks
02:00 PM - 06:30 PM Abstract 043 - Vertigo and Dizziness: Are Associates or Parts of Primary Headache Disorders?
02:00 PM - 06:30 PM Abstract 044 - Selective Gray Matter Atrophy in the Pain-Matrix Network in Cluster Headache
02:00 PM - 06:30 PM Abstract 045 - Development of New Patient-Reported Outcome Measures in Chronic Migraine
02:00 PM - 06:30 PM Abstract 046 - Serial Polysomnography in Cluster Headache Shows No Association with REM Sleep
02:00 PM - 06:30 PM Abstract 047 - Functional Connectivity of the Visual Network in Patients with Migraine and Different Disease Phenotypes
02:00 PM - 06:30 PM Abstract 048 - Evaluation of Anger, Anger Expression Style and Mood Profiles in Tension-Type Headache
02:00 PM - 06:30 PM Abstract 049 - Sleep Disorders and Cervical Radiculopathy Are Prevalent in Headache Patients
02:00 PM - 06:30 PM Abstract 050 - Reversible Cerebral Vasoconstriction Syndrome: Treatment with Combined Intraarterial Verapamil Infusion and Intracranial Angioplasty
02:00 PM - 06:30 PM Abstract 051 - Admission NIHSS and Endovascular Treatment Outcomes: A Single Center Experience
02:00 PM - 06:30 PM Abstract 052 - Intra-Arterial Therapy in Acute Ischemic Stroke Patients with Elevated INR
02:00 PM - 06:30 PM Abstract 053 - Safety of Endovascular Intervention for Acute Ischemic Stroke without General Anesthesia
02:00 PM - 06:30 PM Abstract 054 - Comparative Temporal Analysis of Endovascular Intervention for Acute Ischemic Stroke with and without General Anesthesia
02:00 PM - 06:30 PM Abstract 055 - Accuracy of Ischemic Stroke Diagnosis at Off-Site Emergency Departments among Patients Treated by Drip and Ship Paradigm
02:00 PM - 06:30 PM Abstract 056 - Baseline Imaging and Clinical Parameters for Prediction of Basal Ganglionic Hemorrhage in Endovascular Therapy for Acute M1 Occlusions
02:00 PM - 06:30 PM Abstract 057 - Why Are Patients Excluded from Intravenous Alteplase Therapy after Acute Ischemic Stroke? The University of California, San Diego Experience
02:00 PM - 06:30 PM Abstract 058 - Does Higher Dose of IV Tissue Plasminogen Activator Make More Thrombus Resolution in Patient with Middle Cerebral Artery Occlusion?
02:00 PM - 06:30 PM Abstract 059 - What Is the Impact of Pre-Hospital Provider Diagnosis of Stroke?
02:00 PM - 06:30 PM Abstract 060 - Symptomatic Intracranial Hemorrhage after Intra-Arterial Revascularization in Orally Anticoagulated Patients with Acute Ischemic Stroke
02:00 PM - 06:30 PM Abstract 061 - Angiographic Course [amp] Clinical Outcomes of Patients with Intracranial NonOcclusive Thrombus iNOT Treated by IVTPA [amp] Endovascular Techniques
02:00 PM - 06:30 PM Abstract 062 - Dissociation of Early Outcome of Aphasia Versus Other Deficits after IV-rtPA Thrombolysis in Acute Stroke Patients
02:00 PM - 06:30 PM Abstract 063 - Better Outcome in Smokers Treated by Intravenous rt-PA for Acute Cerebral Ischaemia: A Decoy Rather Than a Pharmacological Effect
02:00 PM - 06:30 PM Abstract 064 - Plasma and Echocardiographic Predictive Parameters for Differentiating Subtypes of Acute Ischemic Stroke
02:00 PM - 06:30 PM Abstract 065 - Accuracy of History of Baseline Warfarin Use in Potential Candidates for Thrombolytic Treatment among Patients with Acute Ischemic Stroke
02:00 PM - 06:30 PM Abstract 066 - Predictors of Neurologic Deterioration in Large Vessel Strokes Presenting outside the Traditional Treatment Window
02:00 PM - 06:30 PM Abstract 067 - Timing of Hospital Arrival among GWTG Stroke Participants 2003-2009: Trends, Variations, and Implications
02:00 PM - 06:30 PM Abstract 068 - Extent of Acute Hydrocephalus after Subarachnoid Hemorrhage as a Risk Factor for Poor Functional Outcome
02:00 PM - 06:30 PM Abstract 069 - Language Screening Test in Five Minutes: Validation of a New Aphasia Screening - Tool for Acute Stroke Patients
02:00 PM - 06:30 PM Abstract 070 - Malignant Acute Carotid Occlusion: Can We Identify and Intervene on Those Destined for Early Progression?
02:00 PM - 06:30 PM Abstract 071 - In Hospital Adminstration of Statins Results in Immediate Benefit: A Short-Term Outcome Study
02:00 PM - 06:30 PM Abstract 072 - Attitude in the General Population towards Decompressive Surgery for Space-Occupying Middle Cerebral Artery (MCA) Infarction. A Population-Based Survey
02:00 PM - 06:30 PM Abstract 073 - Adherence to tPA Administration Standards Appears Independent of Resident Physicians' Level of Training
02:00 PM - 06:30 PM Abstract 074 - Dynamic Endovascular, Vascular and Parenchymal Changes during Adult Ischemic Stroke: A Pilot Study
02:00 PM - 06:30 PM Abstract 075 - Still SMART: Favorable Clinical Outcomes Persist after Eliminating Mild Stroke Cases
02:00 PM - 06:30 PM Abstract 076 - Intracranial Calcification Has Protective Effect Against Occurrence of Vasospasm after Aneurismal Subarachnoid Hemorrhage
02:00 PM - 06:30 PM Abstract 077 - Non Traumatic Subarachnoid Hemorrhage of the Convexity
02:00 PM - 06:30 PM Abstract 078 - Pharmacological Systolic Blood Pressure Reduction and Risk of New Renal Impairment among Patients with Acute Intracerebral Hemorrhage
02:00 PM - 06:30 PM Abstract 079 - Who Benefits from External Ventricular Drains in Intracerebral Hemorrhage?
02:00 PM - 06:30 PM Abstract 080 - Retinal Vessel Changes Associated with Cerebral Amyloid Angiopathy: A Case Control Study
02:00 PM - 06:30 PM Abstract 081 - Cerebral Infarction from Vasospasm after Aneurysmal Subarachnoid Hemorrhage. A Restrospective Analysis from a Private Hospital at Monterrey, Mexico
02:00 PM - 06:30 PM Abstract 082 - Elevated Blood Pressure Causes Larger Hematoma in a Rat Model of Intracerebral Hemorrhage
02:00 PM - 06:30 PM Abstract 083 - Circulating Tight-Junction Proteins as Predictors of Clinically Evident Hemorrhagic Transformation in Ischemic Stroke Patients
02:00 PM - 06:30 PM Abstract 084 - Reported Antiplatelet Use Influences Long-Term Outcome Independently in Deep Intracerebral Hemorrhage
02:00 PM - 06:30 PM Abstract 085 - Does the Size of Platelet Matter in the Occurrence of Intracranial Hemorrhage? A Retrospective Clinical Study
02:00 PM - 06:30 PM Abstract 087 - Intracranial Hemorrhages in a Patient with Poems Syndrome and Castleman's Disease
02:00 PM - 06:30 PM Abstract 088 - Initial Transcranial Doppler Velocity Predicts Development of Symptomatic Vasospasm in Aneurysmal Subarachnoid Hemorrhage
02:00 PM - 06:30 PM Abstract 090 - Pre-Admission beta Blockers Decrease the Incidence of Neurogenic Myocardial Stunning in Aneurysmal Subarachnoid Hemorrhage
02:00 PM - 06:30 PM Abstract 091 - Elevation of Neutrophils and Matrix Metalloproteinase-2 in Cerebral Vasospasm Following Subarachnoid Hemorrhage
02:00 PM - 06:30 PM Abstract 092 - Warfarin-Associated Intracerebral Hemorrhage: Mayo Clinic Arizona's Experience
02:00 PM - 06:30 PM Abstract 093 - Diffusion Restriction on MRI Leads to Worse Outcomes after Intracerebral Hemorrhage
02:00 PM - 06:30 PM Abstract 094 - Blood Pressure at Hospital Presentation as a Risk Factor for Early-Onset Seizures in Patients with Spontaneous Supratentorial Intracerebral Hemorrhage (ICH)
02:00 PM - 06:30 PM Abstract 095 - Outcomes in Elderly Intracerebral Hemorrhage Patients with Feeding Tube or Tracheostomy
02:00 PM - 06:30 PM Abstract 096 - Angiographic Yield in Spontaneous Intracerebral Hemorrhage: A Retrospective Study of 223 Patients
02:00 PM - 06:30 PM Abstract 097 - UCLA ICH Grading System Is a Better Prognostic Tool for Spontaneous Intracerebral Hemorrhage When Assessed at 24 Hours after the Event
02:00 PM - 06:30 PM Abstract 098 - Risk of In-Hospital Pneumonia among Intracerebral Hemorrhage Patients
02:00 PM - 06:30 PM Abstract 099 - Volumetric and Quantitative Analysis of Subcortical Structures in Progressive Supranuclear Palsy
02:00 PM - 06:30 PM Abstract 100 - Multisystem Atrophy: Clinical, Demographic and Imagenologic Characteristics in an Argentinean Cohort
02:00 PM - 06:30 PM Abstract 101 - Electrophysiological Biomarkers of Incidental Lewy Body Disease
02:00 PM - 06:30 PM Abstract 102 - Laterality of Clinical Symptoms and Dopamine Transporter Imaging in Corticobasal Degeneration
02:00 PM - 06:30 PM Abstract 103 - Parkinson Disease and Amyotrophic Lateral Sclerosis: Interaction between Language and Motor Systems
02:00 PM - 06:30 PM Abstract 104 - A DTI Study of STN Connectivity in Parkinson's Disease and Progressive Supranuclear Palsy
02:00 PM - 06:30 PM Abstract 105 - Reevaluation of a Japanese Family with Perry Syndrome
02:00 PM - 06:30 PM Abstract 106 - Neuropsychological Profile in Atypical Parkinsonian Syndromes
02:00 PM - 06:30 PM Abstract 107 - Is There a Delayed Gastric Emptying of Patients with Multiple System Atrophy? An Analysis Using the 13C-Acetate Breath Test
02:00 PM - 06:30 PM Abstract 108 - Histological Hallmarks of Incidental Lewy Body Disease: Insights into Premotor Parkinson's Disease
02:00 PM - 06:30 PM Abstract 109 - Effects of Transplantation of Neural Stem Cells Derived from Human Induced Pluripotent Stem Cells in a Rat Stroke Model
02:00 PM - 06:30 PM Abstract 110 - Predicting Grasp, Kinetics, and Kinematics of Hand Movement Using Epidural and Subdural Brain Signals
02:00 PM - 06:30 PM Abstract 111 - Placental Mesenchymal Stem Cells Induced into Neurotrophic Factor Producing Cells Protect Neuronal Cells from Hypoxia and Oxidative Stress
02:00 PM - 06:30 PM Abstract 112 - A Novel Immunodeficient Mouse Model of Mucopolysaccharidosis Type 1 (MPS-1, Hurler Syndrome) for Preclinical Trials of Stem Cell Transplantation
02:00 PM - 06:30 PM Abstract 113 - Erythropoetin Decreases Neurotransmitter Release Probability and Enhances Synaptic Plasticity in Mice Hippocampal Slices
02:00 PM - 06:30 PM Abstract 114 - A Non-Peptidic Erythropoietin Mimetic STS-E15 Protects Primary Neurons Against 6-Hydroxydopamine or Glutamate Toxicity without Erythropoietic Activity
02:00 PM - 06:30 PM Abstract 115 - Complications of Intrathecal Baclofen Pump: Prevention and Cure
02:00 PM - 06:30 PM Abstract 116 - Monomethyl Fumarate Protects Neurons and Oligodendrocytes Against H2O2-Induced Cytotoxicity
02:00 PM - 06:30 PM Abstract 117 - Relationship between AQP4 and Blood-Brain Barrier Damage Following Intracerebral Hemorrhage
02:00 PM - 06:30 PM Abstract 118 - Valproic Acid Attenuates Apoptosis of Cultured Neurons and Astrocytes Induced by Thrombin: Potential Roles of Histone Deacetylase Inhibition
02:00 PM - 06:30 PM Abstract 119 - The Pleotrophic Effects of IGF-I on Human Spinal Cord Neural Progenitor Cells
02:00 PM - 06:30 PM Abstract 120 - Progressive Motor Deficit in N88S Mutant Seipin-Transgenic Mice: A Mouse Model of Seipinopathy/Seipin/BSCL2-Related Motor Neuron Diseases
02:00 PM - 06:30 PM Abstract 121 - RGNEF, a Novel NFL mRNA Binding Protein That Forms Pathological Aggregates in ALS, Is Upregulated in Spinal Motor Neurons in Response to Sciatic Injury in C57BL/6 but Not NFL -/- Mice
02:00 PM - 06:30 PM Abstract 122 - Dysregulated Environmental Responses Either Promote Motoneuron Death or Fail To Support Motoneuron Survival in an ALS Mouse Model
02:00 PM - 06:30 PM Abstract 123 - Induced Pluripotent Stem Cells Generated from Fibroblasts of ALS Patients with TDP-43 Mutations: In Vitro Characterization of Pluripotency and Directed Motor Neuron Differentiation
02:00 PM - 06:30 PM Abstract 125 - Identification of Epigenetic Modifications as Biomarkers for Amyotrophic Lateral Sclerosis
02:00 PM - 06:30 PM Abstract 126 - Viral Hypothesis in Sporadic Amyotrophic Lateral Sclerosis (sALS)
02:00 PM - 06:30 PM Abstract 127 - Targeting of Peripheral Ly6CHi/CCR2 Inflammatory Monocytes Slows Disease Progession and Decreases Neuronal Damage in a Mouse Model of ALS
02:00 PM - 06:30 PM Abstract 128 - Optineurin Gene Mutations in a Cohort of Italian Amyotrophic Lateral Sclerosis Patients
02:00 PM - 06:30 PM Abstract 129 - Phenotype Expression in Women with CMT1X
02:00 PM - 06:30 PM Abstract 130 - The Mutational Spectrum of Charcot-Marie-Tooth Disease Type II in Chinese Population on Taiwan
02:00 PM - 06:30 PM Abstract 131 - X-Linked Hereditary Motor and Sensory Neuropathy Caused by a Mutation of PDHA1 gene: Possible Link to CMTX2? A Case Report
02:00 PM - 06:30 PM Abstract 132 - Novel Mutation in NEFL Gene in a Patient with Axonal Charcot-Marie-Tooth Disease
02:00 PM - 06:30 PM Abstract 133 - Glial-Cell Derived Neurotrophic Factor Is a Potent Inducer of Human Endoneurial Endothelial Cell Tight Junction Specialization Via Tyrosine Kinase Dependent Signaling Pathways
02:00 PM - 06:30 PM Abstract 134 - Dorsal Root Ganglion Neurons Develop Insulin Resistance through Decreased Akt Signaling in Response to Hyperinsulinemia
02:00 PM - 06:30 PM Abstract 135 - Vascular Endothelial Growth Factor Potently Induces Human Endoneurial Endothelial Cell Proliferation, Angiogenesis and Wound Healing Ex Vivo
02:00 PM - 06:30 PM Abstract 136 - EEG-Based Assessment of Language Lateralization in Humans
02:00 PM - 06:30 PM Abstract 137 - Utility of Electroencephalography during Tilt-Table Tests
02:00 PM - 06:30 PM Abstract 138 - Interhemispheric Inbalance Occurring from the Early Stages after Stroke: A TMS Study
02:00 PM - 06:30 PM Abstract 139 - Time Interval Required for Background Rhythm Slowing on Electroencephalogram (EEG) To Return to Baseline after Electrographic Seizures
02:00 PM - 06:30 PM Abstract 140 - Early Detection of Hepatic Encephalopathy in Preclinical Stage with Evoked Response Studies: A Randomised Control Trial
02:00 PM - 06:30 PM Abstract 141 - An ImPRESsive EEG: Novel EEG Features of Posterior Reversible Encephalopathy Syndrome
02:00 PM - 06:30 PM Abstract 142 - Seizures during Routine Electroencephalography (rEEG) in the Pediatric Age Group
02:00 PM - 06:30 PM Abstract 143 - Increased Use-Dependent Plasticity in Older Adults with Primary Insomnia (PI)
02:00 PM - 06:30 PM Abstract 144 - Diagnostic Efficacy of Ambulatory Electroencephalography Compared to Intensive Video-EEG Monitoring
02:00 PM - 06:30 PM Abstract 145 - Visual Evoked Potentials for the Diagnosis of Multiple Sclerosis: Limitations Early in the Course of Disease
02:00 PM - 06:30 PM Abstract 146 - Juvenile Myoclonic Epilepy in Saudi Arabia: Clinical and Genetic Evidences for Autosomal Recessive Inheritance
02:00 PM - 06:30 PM Abstract 147 - Rational Promiscuity: A Framework for Drug Development in Epilepsy and Other Central Nervous System Disorders
02:00 PM - 06:30 PM Abstract 148 - Antiinflammatory Effects of Carisbamate
02:00 PM - 06:30 PM Abstract 149 - Exploring Novel Mechanisms by Which Bcl-xL Regulates Neuronal Activity
02:00 PM - 06:30 PM Abstract 150 - Lacosamide Does Not Alter Bone Densitometry Parameters in Juvenile Dogs
02:00 PM - 06:30 PM Abstract 151 - Ca2+ Channel Promiscuity of Small Conductance Ca2+-Activated K+ Channels (SK) in Hippocampal Pyramidal Neurons
02:00 PM - 06:30 PM Abstract 152 - Seizure Outcomes Following Multilobar Epilepsy Surgery
02:00 PM - 06:30 PM Abstract 153 - Idiopathic Generalized Epilepsy and the Evening Circadian Chronotype: Can a Simple Question Help with the Diagnosis?
02:00 PM - 06:30 PM Abstract 154 - Is There a Correct Way To Discontinue the Ketogenic Diet?
02:00 PM - 06:30 PM Abstract 155 - Repeat Surgery of Hypothalamic Hamartoma for Refractory Epilepsy
02:00 PM - 06:30 PM Abstract 156 - EEG Patterns in Angelman Syndrome: Correlation with Genotype
02:00 PM - 06:30 PM Abstract 157 - Epilepsy in Gliomas
02:00 PM - 06:30 PM Abstract 158 - Risk Factors for New Onset Refractory Status Epilepticus in the Pediatric Intensive Care Unit
02:00 PM - 06:30 PM Abstract 159 - Treatment of Infantile Spasms at a Tertiary Care Center in the United States
02:00 PM - 06:30 PM Abstract 160 - Detection of HHV6 Genome in MTS and FCD Samples from Refractory Epilepsy Patients
02:00 PM - 06:30 PM Abstract 161 - Secondary Epilepsy and Criteria for Neurocysticercosis: When Is Enough Enough?
02:00 PM - 06:30 PM Abstract 162 - Immunohistochemical Characterization of Microglia in Nasu-Hakola Disease Brains
02:00 PM - 06:30 PM Abstract 163 - Aging-Related Cognitive Impairment Is Correlated with Metabolic and Synaptic Changes in Rat Hippocampus
02:00 PM - 06:30 PM Abstract 164 - Dysregualtion of Autophagy by beta-Amyloid (A[beta]) Is through mTOR Dependent and Independent Pathways
02:00 PM - 06:30 PM Abstract 165 - Association of Cognitive Deficits with Synchronous Neural Interactions as Revealed by Magnetoencephalography: Application on Alzheimer's Disease
02:00 PM - 06:30 PM Abstract 166 - Memantine Multiple Mechanisms of Action in Preclinical Models of Alzheimer's Disease
02:00 PM - 06:30 PM Abstract 167 - Humoral Immunity Profile of Elderly Individuals Reveals Differences between Alzheimer's Disease Patients and Cognitively Normal Controls
02:00 PM - 06:30 PM Abstract 168 - Lycopene and F2 Isoprostanes Predict Cognitive Deterioration in Patients with Mild Cognitive Impairment and Alzheimer's Disease
02:00 PM - 06:30 PM Abstract 169 - Isradipine for Treatment of Alzheimer's Disease Pathology
02:00 PM - 06:30 PM Abstract 170 - Plasma and Cerebrospinal Fluid Metals in Alzheimer's Disease
02:00 PM - 06:30 PM Abstract 171 - Inhibition of Tau Phosphorylation by Modified Saline Containing Charge-Stabilized Nanostructures: Implications for Alzheimer's Disease
02:00 PM - 06:30 PM Abstract 173 - The Incremental Cost of Alzheimer's Disease to the California State Medicaid Program
02:00 PM - 06:30 PM Abstract 174 - Medication Adherence among Patients with Alzheimer's Disease and Related Dementia
02:00 PM - 06:30 PM Abstract 175 - Automatic Video Monitoring System To Detect Apathy in Mild Cognitive Impairment
02:00 PM - 06:30 PM Abstract 176 - Cognitive Predictors of Severe Cerebral Amyloid Angiopathy in Persons with Alzheimer's Disease
02:00 PM - 06:30 PM Abstract 177 - A Meta-Analysis of Multicenter Randomized Controlled Trials for the Treatment of Memory Loss (MCI/AD) Utilizing Quality Standards Specified by the CONsolidated Standards of Reporting Trials (CONSORT 2010) Statement
02:00 PM - 06:30 PM Abstract 178 - A Cost-Utility Analysis of Rivastigmine Transdermal System for the Treatment of Patients with Alzheimer's Disease in Mexico
02:00 PM - 06:30 PM Abstract 179 - Factors Important to Cognitively Normal Adults in Decisions about Alzheimer's Disease Secondary Prevention Trial Participation
02:00 PM - 06:30 PM Abstract 180 - Application of Hierarchical Bayesian Cognitive Processing Models in Clinical Trials for Alzheimer's Disease
02:00 PM - 06:30 PM Abstract 181 - Using the CONSORT 2010 Criteria To Analyze Quality of Data Reported in Randomized Controlled Trials of Pharmacotherapy of Dementia and Mild Cognitive Impairment (MCI)
02:00 PM - 06:30 PM Abstract 182 - Subjective Memory Complaints May Predict Incident MCI in a Population-Based Cohort
02:00 PM - 06:30 PM Abstract 183 - Longitudinal Performance on the Clock Drawing Test in Parkinson Disease Patients
02:00 PM - 06:30 PM Abstract 184 - Comparing the Usefulness of the INECO Frontal Screening (IFS) and the Frontal Assessment Battery (FAB) in Frontotemporal Dementia
02:00 PM - 06:30 PM Abstract 185 - ERP Studies of Preclinical Alzheimer's Disease: P600 Abnormalities Are Common in Elderly Persons Who Later Develop MCI or AD Pathology
02:00 PM - 06:30 PM Abstract 186 - Computer Self-Test (CST) Generated Cognitive Patterns: Distinguishing among Frontotemporal Dementia, Alzheimer's Disease and Healthy Older Adults
02:00 PM - 06:30 PM Abstract 187 - Different Risk of Dementia in Mild Cognitive Impairment Subtypes
02:00 PM - 06:30 PM Abstract 188 - Simultaneous Investigation of Metabolite Changes in Both Anterior and Posterior Cingulate Gyri as a Dynamic Biomarker from Preclinical to Clinical Alzheimer's Disease
02:00 PM - 06:30 PM Abstract 189 - Differential Item Functioning of the Montreal Cognitive Assessment: Impact of Race, 好色先生 and Gender
02:00 PM - 06:30 PM Abstract 190 - Automated Quantitative Analysis of Clustering and Switching on Semantic Verbal Fluency Test for Predicting the Rate of Cognitive Decline
02:00 PM - 06:30 PM Abstract 191 - Predicting Risk of Dementia Based on Automated Quantitative Analysis of Clustering and Switching on Semantic Verbal Fluency Test
02:00 PM - 06:30 PM Abstract 192 - Clinical and Diagnostic Markers of Sporadic Creutzfeldt-Jakob Disease (sCJD) at a Single Institution from 2005-2010
02:00 PM - 06:30 PM Abstract 193 - Is There an Impact of Cognitive Activity on the Brain Metabolism?
02:00 PM - 06:30 PM Abstract 194 - Dementia and Lower Seizure Threshold
02:00 PM - 06:30 PM Abstract 195 - Our Experience of a Multi-Dimensional Meta-Memory Scale (MFQ) for Characterization of Subjective Cognitive Impairment in Clinical Practice
02:00 PM - 06:30 PM Abstract 196 - Movement and Position Sense Neglect and Extinction: Expanding our Understanding on Inattention
02:00 PM - 06:30 PM Abstract 197 - Nonconvulsive Status Epilepticus Presenting with Anterograde Amnesia and Paroxysmal Anomic Aphasia: Glioblastoma of the Left Temporal Lobe
02:00 PM - 06:30 PM Abstract 198 - Hallucinations and Aberrant Perceptions among Young Healthy Adult Population
02:00 PM - 06:30 PM Abstract 199 - Gender Differences in Cognitive Performance: Influence of Arithmetic Task Difficulty on Bilateral Prefrontal Cortex Oxygenation
02:00 PM - 06:30 PM Abstract 200 - What Neurologists Should Know about Catatonia: A Potentially Reversible Etiology of Altered Mentation and Rigidity
02:00 PM - 06:30 PM Abstract 201 - Measuring Top-Down Control Activity Associated with Selective Visual Attention
02:00 PM - 06:30 PM Abstract 202 - Chronic Mild Visuospatial Neglect Is Common in Children Following Stroke
02:00 PM - 06:30 PM Abstract 203 - Atextia
02:00 PM - 06:30 PM Abstract 204 - Timing Behavior as a Clinical Index of Global Cerebral Ischemia in Patients on Ventricular Assist Support
02:00 PM - 06:30 PM Abstract 205 - Variable Neurologic Features in Genetically Defined Lipoid Proteinosis
02:00 PM - 06:30 PM Abstract 206 - Brain Iron Accumulation Independently Contributes to Cognitive Impairments in Minimal Hepatic Encephalopathy
02:00 PM - 06:30 PM Abstract 207 - Limbic Encephalitis: When Is a Brain Biopsy Indicated?
02:00 PM - 06:30 PM Abstract 208 - Ophthalmic Evaluations in Clinical Studies of Fingolimod (FTY720) in Multiple Sclerosis (MS)
02:00 PM - 06:30 PM Abstract 209 - Association of Retinal Nerve Fiber Layer Thickness, Macular Volume and Brain Atrophy in Secondary Progressive Multiple Sclerosis
02:00 PM - 06:30 PM Abstract 210 - Diffusion Tensor Imaging of Optic Neuritis and Its Recovery
02:00 PM - 06:30 PM Abstract 211 - Volume of Visual Cortex Activation Is More Closely Related to Macular Volume Than Peripapillary Retinal Nerve Fiber Layer Thickness Following Optic Neuritis
02:00 PM - 06:30 PM Abstract 212 - Optic Nerves in Primary Progressive MS Are Possibly Impaired by a Degenerative Process
02:00 PM - 06:30 PM Abstract 213 - Topography of Axonal Loss in Retina after Optic Neuritis in NMO and MS
02:00 PM - 06:30 PM Abstract 214 - Effects of Long-Term ([gt]5 Years) Daclizumab Therapy on Lymphocyte Subpopulations - Comparison of Immediate Ex-Vivo Immunophenotyping with Commercially-Available Assay
02:00 PM - 06:30 PM Abstract 215 - P2X7 Purinergic Receptor on Monocytes of Patients with Multiple Sclerosis: Effects of Glatiramer Acetate Immune Modulation
02:00 PM - 06:30 PM Abstract 216 - Effects of Cladribine Tablets in Lymphocyte Subtypes: Insights from the Phase III, 96-Week, Double-Blind CLARITY Study
02:00 PM - 06:30 PM Abstract 217 - Daclizumab Inhibits Expansion of Antigen (Ag)-Specific T Cells by Blocking IL-2 Transpresentation by Dendritic Cells
02:00 PM - 06:30 PM Abstract 218 - In Vivo Recall Stimulation of Glatiramer Acetate-Specific CD4+ T Cells Protects from CD8+ T Cell-Mediated Experimental Autoimmune Encephalomyelitis
02:00 PM - 06:30 PM Abstract 219 - Natural and Inducible Regulatory T Cells in Myxovirus-Protein A-Induced Multiple Sclerosis Patients Treated with IFN[beta]
02:00 PM - 06:30 PM Abstract 220 - Changes in Circulating Dendritic Cells Subsets, T-Cells and B-Cells in Patients with Multiple Sclerosis after Cladribine Therapy
02:00 PM - 06:30 PM Abstract 221 - T-Effective, T-Regulatory and B-Cells in Newly Natalizumab-Treated MS Patients: Implications for Recognition of Early Response to Therapy
02:00 PM - 06:30 PM Abstract 222 - Selectivity of [alpha]4[beta]1 Integrin vs. [alpha]4[beta]7 Integrin Inhibition by ELND002 Is Reflected by Soluble VCAM vs. Soluble MAdCAM Downregulation In Vivo
02:00 PM - 06:30 PM Abstract 223 - Decreased Serum CD4 in a Patient with PML Treated with Natalizumab
02:00 PM - 06:30 PM Abstract 224 - Long-Term Efficacy and Tolerability of Natalizumab Treatment in Multiple Sclerosis Patients: A Multicenter Experience
02:00 PM - 06:30 PM Abstract 225 - Multiple Sclerosis Associated Fatigue during Disease Modifying Treatment with Natalizumab, Interferon-beta and Glatirameracetate
02:00 PM - 06:30 PM Abstract 226 - Relationship between Adherence to Disease-Modifying Drugs and Severe Relapses, Direct and Indirect Costs among Employees with Multiple Sclerosis
02:00 PM - 06:30 PM Abstract 227 - Effects of Treatment of Sleep Disorders on Clinical Symptoms in Multiple Sclerosis Patients
02:00 PM - 06:30 PM Abstract 228 - Predictors of Suboptimal Response to Second-Line Treatments in Multiple Sclerosis
02:00 PM - 06:30 PM Abstract 229 - Laquinimod Pharmacokinetics and Animal Dosing
02:00 PM - 06:30 PM Abstract 230 - Clinical Response to Plasmapheresis in Patients with Multiple Sclerosis and Other Demyelinating CNS Diseases
02:00 PM - 06:30 PM Abstract 232 - Impact of Combined Dalfampridine Extended Release and Interferon-[beta] on Patient Reported Outcomes in Placebo-Controlled Clinical Trials
02:00 PM - 06:30 PM Abstract 233 - Natalizumab Treatment in a Case of Neuromyelitis Optica
02:00 PM - 06:30 PM Abstract 234 - Hematological Side Effects of Natalizumab: Correlation to Clinical Outcome
02:00 PM - 06:30 PM Abstract 235 - Do Multiple Sclerosis Patients Understand Risk? Survey Results from the NARCOMS Registry
02:00 PM - 06:30 PM Abstract 236 - Doses of Dalfampridine Extended Release Tablets Greater Than 10 mg Twice Daily Are Associated with Increased Adverse Events but Not Increased Efficacy
02:00 PM - 06:30 PM Abstract 237 - Leukaemia Related to Mitoxantrone Therapy in MS Patients: Mortality Rate and Relationship with the MTX Lifetime Cumulative Dose
02:00 PM - 06:30 PM Abstract 238 - Impact of Renal Function on the Clearance of PEGylated Interferon Beta-1a
02:00 PM - 06:30 PM Abstract 239 - Long Term Safety and Efficacy of Mitoxantrone in MS-Treatment
02:00 PM - 06:30 PM Abstract 240 - BAF312 Dose-Titration Scheme Significantly Attenuates Initial Heart Rate Reducing Effects in Healthy Subjects
02:00 PM - 06:30 PM Abstract 241 - Management of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy (PML) with a Complex Regimen Including the Oral Lipophilic Nucleotide Analogue CMX001
02:00 PM - 06:30 PM Abstract 242 - Alemtuzumab and Thyroid Autoimmunity in Relapsing-Remitting Multiple Sclerosis Patients in CAMMS223
02:00 PM - 06:30 PM Abstract 243 - Tolerability Profile of Cladribine Tablets Therapy for Patients with Relapsing-Remitting Multiple Sclerosis: Factors Contributing to Treatment Completion in the Double-Blind, 96-Week, Placebo-Controlled CLARITY Study
02:00 PM - 06:30 PM Abstract 244 - Side-Effects of Mitoxantrone Are Not Dose Dependant and Not Limited to Cardiotoxicity and Treatment Related Leucaemia
02:00 PM - 06:30 PM Abstract 245 - Increased Frequency of Hypophosphatemia with Serial, Triple-Dose Gadolinium in Multiple Sclerosis Patients
02:00 PM - 06:30 PM Abstract 246 - Hypersensitivity Reactions during Natalizumab therapy: Possible Approach
02:00 PM - 06:30 PM Abstract 247 - Cardiotoxicity in Multiple Sclerosis Patients Treated with Less Than Half the Maximum Allowed Lifetime Dose ([le]70 mg/m2) of Mitoxantrone
02:00 PM - 06:30 PM Abstract 248 - Risk Stratification for Progressive Multifocal Leukoencephalopathy (PML) in MS Patients: Role of Prior Immunosuppressant Use, Natalizumab-Treatment Duration, and Anti-JCV Antibody Status
02:00 PM - 06:30 PM Abstract 249 - Severe Multiple Sclerosis Relapse under Fingolimod Therapy: Incident or Coincidence?
02:00 PM - 06:30 PM Abstract 250 - Favourable Outcome of Prolonged Immune Reconstitution Inflammatory Syndrome in the Context of Progressive Multifocal Leukoencephalopathy and Herpes Simplex Type 2 Meningoencephalitis in a Patient Treated with Natalizumab for Multiple Sclerosis
02:00 PM - 06:30 PM Abstract 251 - Exploring the Health Care Literacy Needs of Newly Diagnosed Brain Cancer Patients from the Perspectives of Both Patients [amp] Health Care Providers
02:00 PM - 06:30 PM Abstract 252 - The Effects of Adding a Home Fitness Program (HFP) to a Clinical Physical Therapy Program (CPTP) on the Cancer-Related Fatigue Reported by Patients Undergoing Concurrent Chemotherapy and Radiation (CRT) for High-Grade Glioma (HGG)
02:00 PM - 06:30 PM Abstract 253 - Psychological Impact of the Neurofibromatosis Tumor Suppressor Syndrome in Adults
02:00 PM - 06:30 PM Abstract 254 - Supportive Care for Patients Undergoing Craniotomy for Benign Brain Tumors: A Qualitative Study
02:00 PM - 06:30 PM Abstract 255 - Guillain-Barr[eacute] Syndrome in Cancer Patients Undergoing Chemotherapy
02:00 PM - 06:30 PM Abstract 256 - Can Dysesthesias in Taxane Neuropathy Be Predicted by Quantitative Sensory Test and Nerve Conduction?
02:00 PM - 06:30 PM Abstract 257 - Akathisia as a Complication of gamma Knife Surgery
02:00 PM - 06:30 PM Abstract 258 - Unusual Presentation of AML as Acute Thoracic Myelopathy
02:00 PM - 06:30 PM Abstract 259 - SIADH Due to Merkel Cell Carcinoma
02:00 PM - 06:30 PM Abstract 260 - Pituitary Adenoma Complicated By Multifocal Fibrosclerosis Involving Sella and Retroperitoneum
02:00 PM - 06:30 PM Abstract 261 - Ocular Vestibular-Evoked Myogenic Potentials to the Air-Conducted Sound in Patients with Acute Unilateral Superior and Inferior Vestibular Neuritis
02:00 PM - 06:30 PM Abstract 262 - Abnormalities of Saccadic Accuracy in Early Parkinson's Disease with Unilateral Symptoms
02:00 PM - 06:30 PM Abstract 263 - Ocular Myasthenia Gravis (OMG) in an Academic Neuro-Ophthalmology Clinic: A Retrospective Cohort Study
02:00 PM - 06:30 PM Abstract 264 - 0.5% Apraclonidine Test: A New Pharmacologic Test for Horner Syndrome
02:00 PM - 06:30 PM Abstract 265 - Genetic Anticipation in a Korean Family with a Novel CACNA1A Mutation
02:00 PM - 06:30 PM Abstract 266 - Activations of Oculomotor Cerebellar and Visual Cortical Areas in Congenital Nystagmus
02:00 PM - 06:30 PM Abstract 267 - Vestibular Evoked Myogenic Potential (VEMP) and Stabilometry in Bilateral Vestibular Failure (BVF)
02:00 PM - 06:30 PM Abstract 268 - Vestibular Syndrome and Its Diagnosis in an Emergency Room (ER)
02:00 PM - 06:30 PM Abstract 269 - What Terminates Saccades: Brainstem Omnipause Neurons or Cerebellar Fastigial Nucleus?
02:00 PM - 06:30 PM Abstract 270 - Ictal Downbeat Nystagmus in Cardiogenic Vertigo
02:00 PM - 06:30 PM Abstract 271 - A Study of the Time Course of Retinal Nerve Fibre Layer Thickness in Patients with Post-Chiamal Stroke
02:00 PM - 06:30 PM Abstract 272 - Homonymous Hemianopsia: The Tip of the Posterior Cortical Atrophy Iceberg
02:00 PM - 06:30 PM Abstract 273 - First Incidence Study of Temporal Arteritis in South America
02:00 PM - 06:30 PM Abstract 274 - Neuropathy and Regional Cerebellar Atrophy: Integral Components of the Cerebellar Ataxia with Neuropathy and Bilateral Vestibular Areflexia Syndrome (CANVAS)
02:00 PM - 06:30 PM Abstract 275 - Thalamic Astasia from a Highly Selective Centromedian Thalamic Infarction
02:00 PM - 06:30 PM Abstract 276 - Typical and Atypical Cogan's Syndrome (CS)
02:00 PM - 06:30 PM Abstract 277 - Generalized Muscle Claudication as an Initial Symptom of Amyloidosis from Multiple Myeloma
02:00 PM - 06:30 PM Abstract 278 - A Case of Primary Sjogren Syndrome with Sub-Sarcolemmal Crystalline Inclusions on Muscle Biopsy: First Report in the Literature
02:00 PM - 06:30 PM Abstract 279 - Brain Metastasis from Cervical Cancer: What It Is Needed To Know
02:00 PM - 06:30 PM Abstract 280 - Clinical Presentation in Neurosarcoidosis: A Retrospective Study of 71 Cases
02:00 PM - 06:30 PM Abstract 281 - Marchiafava-Bignami Disease in a Non-Alcoholic Female Receiving Cisplatin
02:00 PM - 06:30 PM Abstract 282 - Integrative Mind Brain Medicine: A 12 Week Integrated Neurology and Psychiatry Course for Third Year Medical Students
02:00 PM - 06:30 PM Abstract 283 - Burden of Pseudobulbar Affect on Social Function and Quality of Relationships: Results of a Harris Survey
02:00 PM - 06:30 PM Abstract 284 - Neurological Involvements of Behcet Disease: Epidemiological Aspects, Clinical Features, Treatment and Outcomes (43 Cases)
02:00 PM - 06:30 PM Abstract 285 - Tuberous Sclerosis Complex: Diagnostic Challenges, Presenting Symptoms and Commonly Missed Early Signs
02:00 PM - 06:30 PM Abstract 286 - Adverse Events of IVIg for Neurologic Patients in the Home Care Setting
05:00 PM - 06:30 PM Reception
Faculty Disclosures
Virgilio Gerald H. Evidente, MD, FAAN Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Evidente has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Evidente has received research support from CND. The institution of Dr. Evidente has received research support from Aeon. The institution of Dr. Evidente has received research support from Bukwang Pharmaceuticals. The institution of Dr. Evidente has received research support from Jazz Pharmaceuticals. The institution of Dr. Evidente has received research support from Scion Neurostim. The institution of Dr. Evidente has received research support from Theravance Biopharma. Dr. Evidente has received research support from Cerevance. Dr. Evidente has received research support from Ipsen.
Andrew Gomez-Vargas, MD No disclosure on file
No disclosure on file
Diego Cadavid, MD, FAAN Dr. Cadavid has received personal compensation for serving as an employee of Verge Genomics. Dr. Cadavid has received personal compensation for serving as an employee of Vertex Pharmaceuticals. Dr. Cadavid has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. Cadavid has or had stock in Verge Genomics.Dr. Cadavid has or had stock in Vertex Pharmaceuticals.
Primo M. Delgado, MD Dr. Delgado has nothing to disclose.
Mamatha Pasnoor, MD, FAAN Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx BVBA. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceutical. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amgen.
Gudarz Davar, MD No disclosure on file
Mitchell F. Brin, MD, FAAN Dr. Brin has received personal compensation for serving as an employee of Allergan. Dr. Brin has stock in Allergan.
Jean C. Ouallet Jean C. Ouallet has nothing to disclose.
Ilya Kister, MD, FAAN Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Niklas Beyersdorf, MD No disclosure on file
Jeremy C. Hobart, MD Dr. Hobart has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Hobart has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi.
Sheena K. Aurora, MD Dr. Aurora has received personal compensation for serving as an employee of Alzheimer's Association.
Lara Jehi, MD Dr. Jehi has nothing to disclose.
Bibiana Bielekova, MD, FAAN Dr. Bielekova has received research support from National Institutes of Allergy and Infectious Diseases. Dr. Bielekova has received intellectual property interests from a discovery or technology relating to health care. Dr. Bielekova has received publishing royalties from a publication relating to health care.
Richard C. Burgess, MD, PhD Dr. Burgess has nothing to disclose.
Howard L. Weiner, MD Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
Hector R. Martinez, MD Dr. Martinez has nothing to disclose.
Kristen Babinski, MD Dr. Babinski has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Babinski has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Conway Homer, P.C..
Kavita M. Grover, MD, FAAN Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Grover has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst.
Claudie McGuire, MD No disclosure on file
Per Solberg Sorensen, MD, PhD, FAAN Dr. Sorensen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA.
Shashidhar Kori, MD Dr. Kori has received personal compensation for serving as an employee of Novilla Pharma. Dr. Kori has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Satsuma Pharma. Dr. Kori has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Tonix Pharma. Dr. Kori has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Exalys Pharma. Dr. Kori has received personal compensation in the range of $0-$499 for serving as a Consultant for NewBio Pharma. Dr. Kori has received personal compensation in the range of $0-$499 for serving as a Consultant for Afsci Pharma. Dr. Kori has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Trigemina Inc. Dr. Kori has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Novilla Pharma. Dr. Kori has received stock or an ownership interest from Novilla Pharma. Dr. Kori has received stock or an ownership interest from NewBio Pharma. Dr. Kori has received stock or an ownership interest from Tonix Pharma. Dr. Kori has received intellectual property interests from a discovery or technology relating to health care. Dr. Kori has received intellectual property interests from a discovery or technology relating to health care. Dr. Kori has received personal compensation in the range of $0-$499 for serving as a Reviewer of grant applications with Department of Defense.
Fen Bao Fen Bao has nothing to disclose.
Meena Subramanyam, PhD No disclosure on file
Irene Cortese, MD Dr. Cortese has stock in Keires, AG. Dr. Cortese has stock in Nouscom, AG. Dr. Cortese has stock in PDC*line Pharma.
William P. Neil, MD Dr. Neil has nothing to disclose.
Wolfgang Koehler Wolfgang Koehler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Minoryx. Wolfgang Koehler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vigil. Wolfgang Koehler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for United Leukodystrophy Foundation. Wolfgang Koehler has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for European Leukodystrophy Association. The institution of Wolfgang Koehler has received research support from Minoryx. The institution of Wolfgang Koehler has received research support from Vigil. The institution of Wolfgang Koehler has received research support from SwanBio. The institution of Wolfgang Koehler has received research support from Alexion.
Yonas E. Geda, MD The institution of Dr. Geda has received research support from NIH.
Parampreet Singh, MD No disclosure on file
Lucas Restrepo, MD, PhD Dr. Restrepo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Restrepo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly USA. Dr. Restrepo has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Kelvi/Hypothermia Devices, Inc.. Dr. Restrepo has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Journals, The Neurohospitalist. Dr. Restrepo has stock in Hypothermia Devices, Inc. (dba Kelvi). Dr. Restrepo has stock in Eli Lilly. Dr. Restrepo has received intellectual property interests from a discovery or technology relating to health care.
Michael S. Okun, MD, FAAN Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care.
Sanjeev V. Kothare, MD, FAAN Dr. Kothare has nothing to disclose.
Shoji Tsuji, MD, PhD The institution of Dr. Tsuji has received research support from Novelpharma Co. Ltd..
David W. Dodick, MD, FAAN Dr. Dodick has received personal compensation for serving as an employee of Mayo Clinic. Dr. Dodick has received personal compensation for serving as an employee of Atria Health. Dr. Dodick has received personal compensation for serving as an employee of Thomas Jefferson University . Dr. Dodick has received personal compensation for serving as an employee of Norwegian University of Science and Technology. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopharm Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inside Practice Australia. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical 好色先生 Alliance. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of the Pacific . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medica Communications. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJ Healthcare. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nocira. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vector Psychometrics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Ayya Biosciences. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Dodick has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atria. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Thomas Jefferson University. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medforce. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision HEOR. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canadian Headache Society. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of New England. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Japan. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for KingDevick Technologies. Dr. Dodick has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Precon Health. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ontologics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Matterhorn. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Axon Therapeutics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Cephalgia Group. Dr. Dodick has stock in Healint. Dr. Dodick has stock in Theranica. Dr. Dodick has stock in Aural Analytics . Dr. Dodick has stock in Epien. Dr. Dodick has stock in Matterhorn. Dr. Dodick has stock in Ontologics. Dr. Dodick has stock in Precon Health. Dr. Dodick has stock in King Devick Technologies. Dr. Dodick has stock in Nocira. Dr. Dodick has stock in Exsano. Dr. Dodick has stock in Palion. Dr. Dodick has stock in AYYA Biosciences. Dr. Dodick has stock in Perfood. Dr. Dodick has stock in Cephalgia Group. Dr. Dodick has stock in Atria Health. Dr. Dodick has stock in Man and Science. Dr. Dodick has stock in Eigenlyfe. An immediate family member of Dr. Dodick has stock in ScotiaLyfe. Dr. Dodick has stock in Axon Therapeutics. The institution of Dr. Dodick has received research support from Department of Defense. The institution of Dr. Dodick has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Dodick has received research support from Henry Jackson Foundation. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has a non-compensated relationship as a Chair with American Brain Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Committee member/Course Director with 好色先生 that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair/Immediate Past Chair with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair Global Patient Advocacy Coalition with International Headache Society that is relevant to AAN interests or activities.
Elsdon Storey, FRACP, DPhil No disclosure on file
Stuart D. Cook, MD, FAAN No disclosure on file
Eva Feldman, MD, PhD, FAAN The institution of Dr. Feldman has received research support from National Institutes of Health. The institution of Dr. Feldman has received research support from Centers for Disease Control and Prevention / Agency for Toxic Substances and Disease Registry. The institution of Dr. Feldman has received research support from Juvenile Diabetes Research Foundation. Dr. Feldman has received intellectual property interests from a discovery or technology relating to health care. Dr. Feldman has a non-compensated relationship as a Editorial Board Member with Journal of the Peripheral Nervous System, Experimental Neurology, Nature Neurology Reviews, Neurobiology of Disease, NeuroRx, Journal of Neurology Neurosurgery and Psychiatry, Scientific Reports, Lancet Neurology, Med (Cell Press Journal) that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Editor-in-Chief with Oxford University Press Contemporary Neurology Series that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Membership Committee Member, Strategic Planning Committee Member, and Chair of Section 07 with National Academy of Medicine that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Associate Editor with Annals of Neurology that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Governance Committee Chair with American Neurological Association that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Membership Committee Member, Strategic Planning Committee Member, Chair of Section 07, Neuroscience Forum, Council Member with National Academy of Medicine that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Committee on Making ALS a Livable Disease Member with National Academy of Sciences, Engineering, and Medicine that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Member, Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) External Oversight Committee with National Institutes of Health that is relevant to AAN interests or activities.
David G. Brock, MD No disclosure on file
Seung-Han Lee, MD, PhD Dr. Lee has nothing to disclose.
George Howard, PhD Dr. Howard has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer.
Richard J. Barohn, MD, FAAN Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.
Lewis B. Morgenstern, MD, FAAN No disclosure on file
Christine Lebrun Frenay, MD, FAAN Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique. The institution of Dr. Lebrun Frenay has received research support from FRANCE SEP.
Andrew D. Goodman, MD, FAAN Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Swan Bio. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IMCYSE. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Pfizer. The institution of Dr. Goodman has received research support from Atara. The institution of Dr. Goodman has received research support from Genzyme. The institution of Dr. Goodman has received research support from EMD-Serono.
Mustafa A. Salih, MD, FAAN No disclosure on file
Tobias Loddenkemper, MD, FAAN No disclosure on file
Manoj Mittal, MD Dr. Mittal has nothing to disclose.
Luis E. Morillo, MD No disclosure on file
Kenneth M. Heilman, MD, FAAN Dr. Heilman has received publishing royalties from a publication relating to health care.
Thomas M. Hemmen, MD, PhD Dr. Hemmen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck & Co. Dr. Hemmen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. The institution of Dr. Hemmen has received research support from NIH.
John Markman, MD, FAAN Dr. Markman has received personal compensation for serving as an employee of Eli LIlly.
Shrikant Mishra, MD Dr. Mishra has nothing to disclose.
Mazen M. Dimachkie, MD, FAAN Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medlink. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for TACT / Treat NMD. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Neurological Society of America, Inc . Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Ig Society, Inc. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/Immunovant. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 好色先生 (AAN). Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon Biosciences. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Dimachkie has received personal compensation in the range of $0-$499 for serving as a Consultant for Candid Therapeutics. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Creyon Bio, Inc.. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig Therapeutics. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB Biopharma. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fortrea. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kriya Therapeutics. The institution of Dr. Dimachkie has received research support from NIH. The institution of Dr. Dimachkie has received research support from The Myositis Association. The institution of Dr. Dimachkie has received research support from Biosensics. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care.
Fiona E. Costello, MD Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Accure Therapeutics. Dr. Costello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for the Sumaira Foundation.
Giancarlo Comi, MD Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Peter Rieckmann, MD, FAAN No disclosure on file
Bahman Jabbari, MD, FAAN Dr. Jabbari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Jabbari has received publishing royalties from a publication relating to health care.
Daniel Martinez-Ramirez, MD Dr. Martinez-Ramirez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Mexico. Dr. Martinez-Ramirez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott Mexico.
Martin K. Nicholas, MD No disclosure on file
Jose Gien-Lopez, MD Dr. Gien-Lopez has nothing to disclose.
Michael G. Halmagyi, MD Dr. Halmagyi has nothing to disclose.
Gulden Akdal, MD Dr. Akdal has nothing to disclose.
Hamza I. Maqsood, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Mounzer Kassab, MD No disclosure on file
Bruce I. Ovbiagele, MD, MSc, FAAN Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities.
Lonni Schultz, PhD Dr. Schultz has nothing to disclose.
Scott Pello, MD No disclosure on file
Matthew S. Robbins, MD, FAAN Dr. Robbins has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Robbins has received publishing royalties from a publication relating to health care. Dr. Robbins has a non-compensated relationship as a Board of Directors member, 好色先生 Program speaker with American Headache Society that is relevant to AAN interests or activities. Dr. Robbins has a non-compensated relationship as a Board of Directors member, 好色先生 Program speaker with New York State Neurological Society that is relevant to AAN interests or activities. Dr. Robbins has a non-compensated relationship as a Editorial Board Member with Continuum, 好色先生 that is relevant to AAN interests or activities.
Matthew L. Flaherty, MD Dr. Flaherty has received personal compensation for serving as an employee of Sense Diagnostics, Inc. Dr. Flaherty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boeringher Engelheim. Dr. Flaherty has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Flaherty has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alexion. Dr. Flaherty has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. Dr. Flaherty has stock in Sense Diagnostics, Inc. The institution of Dr. Flaherty has received research support from NINDS. Dr. Flaherty has received intellectual property interests from a discovery or technology relating to health care.
Patrick Vermersch Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS-Celgene. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ad Scientiam. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for La revue des microbiotes. The institution of Patrick Vermersch has received research support from Roche. The institution of Patrick Vermersch has received research support from Sanofi.
Vissia Viglietta, MD No disclosure on file
Jose Luis Etcheverry, MD No disclosure on file
Laura Herbelin No disclosure on file
Chad Carlson, MD, FAAN Dr. Carlson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with US Department of Justice.
Darin Zahuranec, MD, MS The institution of Dr. Zahuranec has received research support from NIH.
Susan Fox, MD, FAAN The institution of Dr. Fox has received research support from MJFF/Safra. The institution of Dr. Fox has received research support from Parkinson Canada. The institution of Dr. Fox has received research support from NIH. Dr. Fox has received publishing royalties from a publication relating to health care.
Jason H. Karlawish, MD No disclosure on file
Barbara C. Jobst, MD, PhD, FAAN Dr. Jobst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Jobst has received research support from Neuropace, Inc.. The institution of Dr. Jobst has received research support from NIH. The institution of Dr. Jobst has received research support from CDC.
Michael Chopp, PhD No disclosure on file
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Immer Armendariz Betancour Immer Armendariz Betancour has nothing to disclose.
Joseph Herbert, MD No disclosure on file
Eva Havrdova, MD Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Chakorn Chansakul, MD No disclosure on file
Shifang Liu No disclosure on file
Didier Leys, MD, FAAN The institution of Dr. Leys has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. Dr. Leys has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley.
Rainer Apfel, MD No disclosure on file
Ildefonso Rodriguez-Leyva, MD, PhD, FAAN Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Laboratorios Columbia.
Neeraj Naval, MD No disclosure on file
Joseph F. Quinn, MD, FAAN Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Retrophin. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Disease Cooperative Study. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Therapeutic Research Institute. Dr. Quinn has a non-compensated relationship as a consultant with Cognition Therapeutics that is relevant to AAN interests or activities.
Junichi Hamada, MD, PhD No disclosure on file
Jessica Carpenter, MD Dr. Carpenter has nothing to disclose.
Alexander-Thomas Kerkau, MD No disclosure on file
Ronald C. Petersen, MD, PhD, FAAN Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Sookyong Koh, MD, PhD No disclosure on file
Gavin Giovannoni, MD Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche-Genentech. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astoria Biologica. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape.
Steven J. Greenberg, MD No disclosure on file
Emilia M. Gatto, MD, FAAN Dr. Gatto has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Gatto has received personal compensation in the range of $0-$499 for serving as a Consultant for Bago Argentina. Dr. Gatto has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bago. Dr. Gatto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Gatto has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Janssen. Dr. Gatto has received research support from Roche. The institution of Dr. Gatto has received research support from CHDI.
Pierre Duquette, MD The institution of Dr. Duquette has received research support from Biogen and Genzyme.
Xiao Hu, PhD No disclosure on file
Sara C. Crystal, MD Dr. Crystal has received personal compensation for serving as an employee of Thirty Madison. Dr. Crystal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Crystal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan.
Takahiro Iizuka, MD The institution of Dr. Iizuka has received research support from EUROIMMUN Japan Co., Ltd.
Tracy T. Batchelor, MD, MPH Dr. Batchelor has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date, Inc. An immediate family member of Dr. Batchelor has received publishing royalties from a publication relating to health care. Dr. Batchelor has received publishing royalties from a publication relating to health care.
Stefan Schwarz, MD No disclosure on file
Hagen B. Huttner, MD, PhD No disclosure on file
Thimmappa S. Anekonda No disclosure on file
Stanley Fahn, MD, FAAN Dr. Fahn has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Stoparkinson Healthcare Systems, LLC; . Dr. Fahn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Retrophin Inc . Dr. Fahn has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Publishers . Dr. Fahn has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Kirkland & Ellis. Dr. Fahn has received publishing royalties from a publication relating to health care.
Neeraj Kumar, MD Dr. Kumar has nothing to disclose.
Scott R. Plotkin, MD, PhD, FAAN Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NFlection Therapeutics. Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Akouos. Dr. Plotkin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SonALAsense. Dr. Plotkin has stock in NFlection Therapeutics. Dr. Plotkin has stock in NF2 Therapeutics. Dr. Plotkin has stock in SonALAsense. Dr. Plotkin has received research support from Children's Tumor Foundation. Dr. Plotkin has received research support from Department of Defense. Dr. Plotkin has received research support from National Institutes of Health. Dr. Plotkin has received intellectual property interests from a discovery or technology relating to health care.
Richard M. Camicioli, MD, FAAN An immediate family member of Dr. Camicioli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi_Tenabi Canada. The institution of Dr. Camicioli has received research support from Canadian Institutes for Health Research. The institution of Dr. Camicioli has received research support from Western Foundation. The institution of Dr. Camicioli has received research support from NIH. The institution of an immediate family member of Dr. Camicioli has received research support from Brain Canada. The institution of an immediate family member of Dr. Camicioli has received research support from Pharmaceutical Sponsored Studies in ALS.
Taim A. Muayqil, MBBS, FRCPC, Msc No disclosure on file
Dennis Meletiche No disclosure on file
Manjit S. Matharu, MD No disclosure on file
Terry D. Heiman-Patterson, MD Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Heiman-Patterson has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. The institution of Dr. Heiman-Patterson has received research support from MTPA. The institution of Dr. Heiman-Patterson has received research support from State of Pennsylvania . The institution of Dr. Heiman-Patterson has received research support from ALS Association. The institution of Dr. Heiman-Patterson has received research support from ALS United. The institution of Dr. Heiman-Patterson has received research support from ALS Hope Foundation.
David Leppert, MD Dr. Leppert has received personal compensation for serving as an employee of GeNeuro. Dr. Leppert has received personal compensation for serving as an employee of GeNeuro. Dr. Leppert has received personal compensation for serving as an employee of Geneuro. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Leppert has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Leppert has received personal compensation in the range of $0-$499 for serving as a Consultant for Orion. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quanterix. Dr. Leppert has stock in Novartis.
Erica Patrick, MD No disclosure on file
Miranda M. Lim, MD, PhD Dr. Lim has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Cognition. Dr. Lim has stock in Applied Cognition. The institution of Dr. Lim has received research support from NIH. The institution of Dr. Lim has received research support from VA. The institution of Dr. Lim has received research support from Department of Defense. The institution of Dr. Lim has received research support from National Science Foundation. Dr. Lim has received publishing royalties from a publication relating to health care.
Mauricio F. Farez, MD Dr. Farez has received personal compensation for serving as an employee of Entelai. Dr. Farez has stock in Entelai. The institution of Dr. Farez has received research support from Fundación Sadosky.
Deborah M. Miller, PhD Dr. Miller has received intellectual property interests from a discovery or technology relating to health care.
Beomseok Jeon, MD Dr. Jeon has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Jeon has received research support from peptron. The institution of Dr. Jeon has received research support from zemvax & kael. Dr. Jeon has received personal compensation in the range of $500-$4,999 for serving as a expert panel with Aspen Neuroscience.
Adil Javed, MD, PhD The institution of Dr. Javed has received research support from Genentech Roche .
Holly A. Shill, MD, FAAN Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Biogen. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KeifeRx. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis Precision Medicine. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl Inc. Dr. Shill has received personal compensation in the range of $0-$499 for serving as a Consultant for Boston Scientific. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America.
Marwan N. Sabbagh, MD, FAAN Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech=Roche. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaptogenix. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anavex. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for CervoMed. Dr. Sabbagh has stock in Neurotau. Dr. Sabbagh has stock in Seq Biomarque. Dr. Sabbagh has stock in uMethod Health. Dr. Sabbagh has stock in Athira. Dr. Sabbagh has stock in Lighthouse Pharmaceuticals. Dr. Sabbagh has stock in Alzheon. The institution of Dr. Sabbagh has received research support from NIH. The institution of Dr. Sabbagh has received research support from ADDF.
John N. Caviness, MD, FAAN Dr. Caviness has nothing to disclose.
Arun Varadhachary, MD, PhD Dr. Varadhachary has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Varadhachary has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Varadhachary has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Varadhachary has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for legal firms .
Patrick J. Gillard, PharmD, MS Mr. Gillard has received personal compensation for serving as an employee of AbbVie. Mr. Gillard has stock in AbbVie.
Mark J. Alberts, MD, FAAN No disclosure on file
Sinead M. Murphy, MD Dr. Murphy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. The institution of Dr. Murphy has received research support from Genomics Medicine Ireland. The institution of Dr. Murphy has received research support from Novartis.
Achim Berthele, MD No disclosure on file
Walter A. Rocca, MD, MPH The institution of Dr. Rocca has received research support from National Institute on Aging - NIH. The institution of Dr. Rocca has received research support from National Heart, Lung, and Blood Institute - NIH.
Paul M. Vespa, MD, FAAN Dr. Vespa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ceribell. Dr. Vespa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ceribell. Dr. Vespa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ceribell. Dr. Vespa has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple. The institution of Dr. Vespa has received research support from NIH. Dr. Vespa has received intellectual property interests from a discovery or technology relating to health care.
Fabienne M. Perren, MD No disclosure on file
Jeffrey A. Cohen, MD Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion.
Vittorio Martinelli Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis, Biogen, Sanofi Genzyme, TEVA and Merck. Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck .
Douglas J. Lanska, MD, FAAN Dr. Lanska has received personal compensation for serving as an employee of Ministry of Health of the Russian Federation. Dr. Lanska has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedScape 好色先生. Dr. Lanska has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink Neurology. Dr. Lanska has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Ebix/Oakstone Publishing. Dr. Lanska has received publishing royalties from a publication relating to health care. Dr. Lanska has received personal compensation in the range of $500-$4,999 for serving as a Invited speaker with Mayo Clinic.
Lisa M. Bateman, MD, FRCPC The institution of Dr. Bateman has received research support from NIH/NINDS.
Norihiro Suzuki No disclosure on file
Yves L. Lapierre, MD No disclosure on file
Letizia Mazzini No disclosure on file
Alfred W. Sandrock, MD, PhD No disclosure on file
Aslam Khaja, MD Dr. Khaja has nothing to disclose.
Juha Punnonen, MD, PhD No disclosure on file
Ania Weck No disclosure on file
Ju-Hun Lee, MD No disclosure on file
William M. Siders, PhD No disclosure on file
Paul Shanahan No disclosure on file
Sean D. Ruland, MD Dr. Ruland has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up to Date. Dr. Ruland has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law Firms.
Laura Cohen No disclosure on file
Bradley F. Boeve, MD, FAAN Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
David E. Blum, MD Dr. Blum has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Blum has stock in Neurona Therapeutics.
Michael Hutchinson, MD Dr. Hutchinson has nothing to disclose.
Lisa Mucha, PhD No disclosure on file
David S. Liebeskind, MD, FAAN Dr. Liebeskind has received research support from Cerenovus. Dr. Liebeskind has received research support from Genentech . Dr. Liebeskind has received research support from Medtronic. Dr. Liebeskind has received research support from Stryker.
Keith A. Josephs, Jr., MD, FAAN Dr. Josephs has nothing to disclose.
Gordon T. Plant No disclosure on file
Gary R. Cutter, PhD Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for onsulting or Advisory Boards: Alexion, Antisense Therapeutics/Percheron, Avotres, Biogen, Clene Nanomedicine, Clinical Trial Solutions LLC, Endra Life Sciences, Cognito Therapeutics, Genzyme, Genentech, Immunic, Klein-Buendel Incorporated, Kyverna Therapeutics, Inc. , Linical, Merck/Serono, Noema, Neurogenesis, Perception Neurosciences, Protalix Biotherapeutics, Regeneron, Revelstone Consulting, Roche, SAB Biotherapeutics, Sapience Therapeutics, Scott&Scott LLP, Tenmile.. Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Data and Safety Monitoring Boards: Applied Therapeutics, AI therapeutics, AMO Pharma, Argenx, Astra-Zeneca, Avexis Pharmaceuticals, Bristol Meyers Squibb, CSL Behring, Cynata Therapeutics, DiamedicaTherapeutics, Horizon Pharmaceuticals, Immunic, Inhibrix, Karuna Therapeutics, Kezar Life Sciences, Medtronic, Merck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma Holdings, Prothena Biosciences, Novartis, Pipeline Therapeutics (Contineum), Regeneron, Sanofi-Aventis, Teva Pharmaceuticals, United BioSource LLC, University of Texas Southwestern.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Edgardo Cristiano, MD Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Helen Petrovitch, MD No disclosure on file
Julian Yang, MD No disclosure on file
Lirong Zhu, MD, PhD No disclosure on file
John E. Duda, MD Dr. Duda has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nature Publishing Group. The institution of Dr. Duda has received research support from Department of Veterans Affairs. The institution of Dr. Duda has received research support from Michael J. Fox Foundation. The institution of Dr. Duda has received research support from Innervace, Incorporated. The institution of Dr. Duda has received research support from National Institutes of Health.
Joseph Hentz No disclosure on file
Randall Kaye, MD No disclosure on file
Liat Hayardeny Nisimov, PhD No disclosure on file
Juan Ignacio Rojas, MD Dr. Rojas has nothing to disclose.
Jay Shah, MD Dr. Shah has nothing to disclose.
Harry Vinters No disclosure on file
John M. Ringman, MD, FAAN The institution of Dr. Ringman has received research support from Avid Pharmaceuticals. The institution of Dr. Ringman has received research support from AltaMed. The institution of Dr. Ringman has received research support from CurePSP.
Raj R. S. Nair, MD No disclosure on file
Afshin A. Divani, PhD The institution of Dr. Divani has received research support from Department of Defense.
Web Ross, MD The institution of Dr. Ross has received research support from Michael J Fox Foundation. The institution of Dr. Ross has received research support from NIH.
Ronald M. Lazar, PhD, FAHA, FAAN, FAAN Dr. Lazar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DiaMedica Therapeutics Inc. . The institution of Dr. Lazar has received research support from National Institutes of Health. Dr. Lazar has received publishing royalties from a publication relating to health care.
Judith Bellmann-Strobl, MD Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Judith Bellmann-Strobl, MD has received research support from Bayer. The institution of Judith Bellmann-Strobl, MD has received research support from NEMOS.
Olukayode Onasanya, MD, FAAN No disclosure on file
Joseph C. Landolfi, DO No disclosure on file
Seo Hyun Kim, MD, PhD No disclosure on file
Douglas L. Arnold, MD, FAAN Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Clario.
Lori A. Shutter, MD, FCCM, FNCS, FAAN, FAAN The institution of Dr. Shutter has received research support from NIH. Dr. Shutter has received publishing royalties from a publication relating to health care.
Sean I. Savitz, MD Dr. Savitz has nothing to disclose.
Pradeep K. Sahota, MD, FAAN The institution of Dr. Sahota has received research support from VA Merit award.
Daita Kaneda, MD No disclosure on file
Mihaela F. Hangan, MD No disclosure on file
Erin M. Dunbar, MD Dr. Dunbar has nothing to disclose.
Dagny N. Holle, MD Dr. Holle has nothing to disclose.
Alberto L. Dubrovsky, MD No disclosure on file
Sayed A. Azizi, MD, PhD, FAAN No disclosure on file
Rup Tandan, MD, FRCP, FAAN Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Apellis. Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amylyx. The institution of Dr. Tandan has received research support from Alexion. The institution of Dr. Tandan has received research support from Apellis. The institution of Dr. Tandan has received research support from Cytokinetics.
Elan D. Louis, MD, MS, FAAN Dr. Louis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer - Merritt's Textbook of Neurology. Dr. Louis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal Firm. The institution of Dr. Louis has received research support from National Institutes of Health. Dr. Louis has received publishing royalties from a publication relating to health care. Dr. Louis has a non-compensated relationship as a Board of Directors with International Essential Tremor Foundation that is relevant to AAN interests or activities. Dr. Louis has a non-compensated relationship as a Medical Advisory Board with HopeNET that is relevant to AAN interests or activities.
Robert Weissert, MD, FAAN No disclosure on file
David S. Knopman, MD, FAAN Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Michael E. Shy, MD, FAAN Dr. Shy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Shy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for DTx Pharma. The institution of Dr. Shy has received research support from NIH. The institution of Dr. Shy has received research support from Muscular Dystrophy Association. The institution of Dr. Shy has received research support from Charcot Marie Tooth Association. The institution of Dr. Shy has received research support from Applied Therapeutics.
Volker A. Knappertz, MD Dr. Knappertz has received personal compensation for serving as an employee of Noema Pharmaceuticals . Dr. Knappertz has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Sutura Pharmaceutical . Dr. Knappertz has received intellectual property interests from a discovery or technology relating to health care.
Benjamin M. Greenberg, MD, FAAN Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has or had stock in GenrAb.Dr. Greenberg has or had stock in Clene.Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Shan Chen, MD, PhD Dr. Chen has nothing to disclose.
Randolph S. Marshall, MD, FAAN The institution of Dr. Marshall has received research support from NIH. Dr. Marshall has received publishing royalties from a publication relating to health care.
Michael Parides, PhD No disclosure on file
Carly Siskind, MS Ms. Siskind has nothing to disclose.
Robert A. Bermel, MD, FAAN Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Bermel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Bermel has received research support from Biogen. The institution of Dr. Bermel has received research support from Roche. The institution of Dr. Bermel has received research support from Novartis. Dr. Bermel has received intellectual property interests from a discovery or technology relating to health care.
Amber Salter, PhD Dr. Salter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gryphon Bio. Dr. Salter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abata Therapeutics. Dr. Salter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sora Neuroscience. Dr. Salter has stock in Owl Therapeutics. The institution of Dr. Salter has received research support from National Multiple Sclerosis Society. The institution of Dr. Salter has received research support from Department of Defense Congressionally Directed Medical Research Program. The institution of Dr. Salter has received research support from Consortium of Multiple Sclerosis Centers.
Jose I. Suarez, MD, FAAN Dr. Suarez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Idorsia. Dr. Suarez has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for The Mayo Clinic.
David C. Preston, MD, FAAN Dr. Preston has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for FBI, US Attorney, Insurance Fraud Investigative Units. Dr. Preston has received publishing royalties from a publication relating to health care.
Friedemann Paul Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb GmbH & Co. KGaA (BMS. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for F&U Confirm. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb GesmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MICE Service. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for VINDICO medical education. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Beijing Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz Internation GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Thailand. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology, Neuroimmunology&Neuroinflammation.
Lon R. White, MD No disclosure on file
William R. Shankle, MD, MS No disclosure on file
Elissaios Karageorgiou, MD, PhD, FAAN Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrtelle. The institution of Dr. Karageorgiou has received research support from European Union.
Mark Cohen Mark Cohen has nothing to disclose.
Jin J. Luo, MD, PhD, FAAN Dr. Luo has nothing to disclose.
Amtul Farheen, MD, FAAN Dr. Farheen has nothing to disclose.
Kyeong-Joon Kim, MD No disclosure on file
Lucia Moiola, MD, PhD Dr. Moiola has nothing to disclose.
Paolo Livrea No disclosure on file
Slawomir Michalak, PhD No disclosure on file
Nabeel Herial, MD, MPH, FAAN Dr. Herial has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic.
Scott M. Lewis, MD, PhD No disclosure on file
Hesham Masoud, MD Dr. Masoud has nothing to disclose.
Andrew Lee, MD No disclosure on file
Ann Scher, PhD, FAAN No disclosure on file
Nestor R. Gonzalez, MD Nestor R. Gonzalez, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. The institution of Nestor R. Gonzalez, MD has received research support from National Institutes of Health. The institution of Nestor R. Gonzalez, MD has received research support from American Heart Associaton.
Brian Grosberg, MD Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Linpharma pharmaceuticals. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Theranica . Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Grosberg has stock in Theranica. The institution of Dr. Grosberg has received research support from Theranica. The institution of Dr. Grosberg has received research support from Amgen. The institution of Dr. Grosberg has received research support from Abbvie. The institution of Dr. Grosberg has received research support from Eli Lilly. The institution of Dr. Grosberg has received research support from Teva. The institution of Dr. Grosberg has received research support from Neurolief. Dr. Grosberg has received publishing royalties from a publication relating to health care.
Susan McPherson, PhD, ABPP/CN, LP No disclosure on file
Thomas Brandt No disclosure on file
Ji S. Kim, MD No disclosure on file
Fernando Vinuela No disclosure on file
Paulus S. Rommer Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. The institution of Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for celgene. The institution of Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for merck. Dr. Rommer has received personal compensation in the range of $0-$499 for serving as a Consultant for sanofi. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sandoz. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for almirall. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Rommer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. The institution of Dr. Rommer has received research support from merck. The institution of Dr. Rommer has received research support from roche. The institution of Dr. Rommer has received research support from amicus. The institution of Dr. Rommer has received research support from biogen.
Marianne Dieterich No disclosure on file
Ji Y. Yun, MD Dr. Yun has nothing to disclose.
Marco R. Di Tullio, MD No disclosure on file
Bander Al-Sowaity, MD No disclosure on file
Shakti Nayar, MD Dr. Nayar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Nayar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Nayar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. Dr. Nayar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Maryam R. Beigi, MD No disclosure on file
Michael B. Robbins, MD No disclosure on file
Pallab K. Bhattacharyya, PhD Dr. Bhattacharyya has nothing to disclose.
Florian Castrop, MD No disclosure on file
Anna Haring No disclosure on file
Ilijas Jelcic, MD No disclosure on file
Eric Williamson, MD Dr. Williamson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG therapeutics. Dr. Williamson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Williamson has received research support from Biogen. Dr. Williamson has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with Veterans administration.
Sonal Mehta, MD Dr. Mehta has nothing to disclose.
Jitendra Sharma, MD No disclosure on file
Hyo Suk Nam No disclosure on file
Bernardo Cacho Diaz, MD, FAAN Dr. Cacho Diaz has nothing to disclose.
Anthony Traboulsee, MD Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Consortium of MS Centers. The institution of Dr. Traboulsee has received research support from MS Canada. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Workshop Chair with Consortium of MS Centers.
Suzanne Hendrix, PhD Dr. Hendrix has received personal compensation for serving as an employee of Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pentara Corporation. Dr. Hendrix has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pentara Corporation. The institution of Dr. Hendrix has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pentara Corporation. Dr. Hendrix has or had stock in Pentara.
Alan Lerner, MD The institution of Dr. Lerner has received research support from Premier applied biosciences. Dr. Lerner has received publishing royalties from a publication relating to health care.
Po-Haong Lu No disclosure on file
Ruth H. Whitham, MD, FAAN No disclosure on file
Joe Munoz No disclosure on file
Apostolos P. Georgopoulos, MD No disclosure on file
Perry K. Richardson, MD Dr. Richardson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for MedForce.
Numthip Chitravas, MD No disclosure on file
Mariela Bettini, MD Dr. Bettini has nothing to disclose.
Tariq B. Alfahad, MD No disclosure on file
Caspar F. Pfueller No disclosure on file
Laura S. Hemmy, PhD Dr. Hemmy has received intellectual property interests from a discovery or technology relating to health care.
Eugene Major, PhD No disclosure on file
Daniel Schwartz, MD No disclosure on file
Pierre Thomas No disclosure on file
Guillermo Videla, MD No disclosure on file
Ewa G. Belniak, MD No disclosure on file
Kathryn L. Jones, PA No disclosure on file
Jorge O. Norscini, MD No disclosure on file
Kristen Kelly, MD No disclosure on file
Eduard Auff No disclosure on file
David Nochlin-Soto, MD No disclosure on file
Yunyan Zhang, MD PhD No disclosure on file
Karthikeyan M. Arcot, MD No disclosure on file
Radoslav Raychev, MD Dr. Raychev has received personal compensation in the range of $0-$499 for serving as a Consultant for Rapid Medical . Dr. Raychev has stock in Rapid Medical . Dr. Raychev has stock in Perflow Medical. Dr. Raychev has stock in Neuronics Medical . Dr. Raychev has stock in Time is Brain INC. Dr. Raychev has received intellectual property interests from a discovery or technology relating to health care. Dr. Raychev has received intellectual property interests from a discovery or technology relating to health care.
Juan A. Burguera, MD, FAAN No disclosure on file
Sang Ho Kim, MD, PhD No disclosure on file
Sushanth Bhat, MD Dr. Bhat has nothing to disclose.
Gabriel Rodriguez, MD No disclosure on file
J R. McCarten, MD No disclosure on file
Carlo Avolio, MD No disclosure on file
Andrea Formella, PharmD, BCPP Dr. Formella has received personal compensation for serving as an employee of Supernus Pharmaceuticals, Inc. Dr. Formella has stock in Supernus Pharmaceuticals, Inc..
Jong-Min Kim, MD No disclosure on file
Lei Shi, MD No disclosure on file
Timothy L. Vollmer, MD, FAAN The institution of Dr. Vollmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen IDEC. The institution of Dr. Vollmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siranax. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squib. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bios. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vollmer has received research support from Rocky Mountain MS Center. The institution of Dr. Vollmer has received research support from Biogen. The institution of Dr. Vollmer has received research support from Actelion. The institution of Dr. Vollmer has received research support from Genentech/Roche. The institution of Dr. Vollmer has received research support from Anokion. The institution of Dr. Vollmer has received research support from TG Therapeutics.
Robert J. Fox, MD, FAAN Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria Biologica. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InnoCare Pharma. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Fox has received research support from National Institutes of Health. The institution of Dr. Fox has received research support from National MS Society. Dr. Fox has received publishing royalties from a publication relating to health care.
Sandra Narayanan, MD, FAAN Dr. Narayanan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Narayanan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MicroVention.
Amit Bar-Or, MD, FRCPC Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
Roberto Del Bo, PhD No disclosure on file
Samuel F. Hunter, MD, PhD The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbview. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMDSerono. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Osmotica. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMDSerono. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Hunter has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Hunter has received research support from Biogen. The institution of Dr. Hunter has received research support from Abbvie. The institution of Dr. Hunter has received research support from Genentech/Roche. The institution of Dr. Hunter has received research support from Janssen. The institution of Dr. Hunter has received research support from Novartis. The institution of Dr. Hunter has received research support from Osmotica. The institution of Dr. Hunter has received research support from Sanofi. Dr. Hunter has received intellectual property interests from a discovery or technology relating to health care. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with MS Views and News. Dr. Hunter has a non-compensated relationship as a CEO - Volunteer with NeuroNexes/Novel Pharmaceutics Institute that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing support with Novartis Pharmaceuticals that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing Support with Osmotica that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing support with Mallinckrodt that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing Support with Sanofi that is relevant to AAN interests or activities.
Brij M. Singh Ahluwalia No disclosure on file
Anjan Chatterjee, MD, FAAN The institution of Dr. Chatterjee has received research support from Templeton Religion Trust. The institution of Dr. Chatterjee has received research support from Henry Jackson Foundation.
Facundo Manes No disclosure on file
Sebastian Zaremba, MD No disclosure on file
Felix Benninger, MD Dr. Benninger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurohelp.
Mathew J. Reeves, PhD, BVSc Mathew J. Reeves, PhD, BVSc has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.
Harry O. Openshaw, MD No disclosure on file
DaiWai Olson The institution of DaiWai Olson has received research support from Neuroptics. The institution of DaiWai Olson has received research support from Chiesi.
Alejandro A. Rabinstein, MD, FAAN Dr. Rabinstein has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shionogi . Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical care/NCS-Springer. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters/UptoDate. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO/DynaMed. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care.
Jeffrey L. Saver, MD, FAAN Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim (prevention only). Dr. Saver has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. Dr. Saver has received stock or an ownership interest from Rapid Medical.
Kirk R. Daffner, MD, FAAN The institution of Dr. Daffner has received research support from Azheimer's Association. The institution of Dr. Daffner has received research support from FUJIFILM.
Erika Driver-Dunckley, MD, FAAN Dr. Driver-Dunckley has nothing to disclose.
Sindhu Ramchandren, MD Dr. Ramchandren has received personal compensation for serving as an employee of Janssen Pharmaceutical Companies of Johnson & Johnson.
Thomas Beach Thomas Beach has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vivid Genomics. Thomas Beach has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. The institution of Thomas Beach has received research support from National Institutes of Health. The institution of Thomas Beach has received research support from Michael J Fox Foundation . The institution of Thomas Beach has received research support from State of Arizona.
Hee Jin Kim, MD No disclosure on file
Charles H. Adler, MD, PhD, FAAN Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care.
Bernhard Hemmer, MD No disclosure on file
Rosebud O. Roberts, MD No disclosure on file
Eric H. Kossoff, MD Dr. Kossoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nutricia. Dr. Kossoff has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Simply Good Foods. Dr. Kossoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cambrooke. Dr. Kossoff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroPace. Dr. Kossoff has received publishing royalties from a publication relating to health care. Dr. Kossoff has received publishing royalties from a publication relating to health care. Dr. Kossoff has received publishing royalties from a publication relating to health care. Dr. Kossoff has received publishing royalties from a publication relating to health care.
Mary Reilly, MD, FRCP, FRCPI The institution of Mary Reilly, MD, FRCP, FRCPI has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alynlam. Mary Reilly, MD, FRCP, FRCPI has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AKCEA. Mary Reilly, MD, FRCP, FRCPI has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inflectis. The institution of Mary Reilly, MD, FRCP, FRCPI has received research support from MRC. The institution of Mary Reilly, MD, FRCP, FRCPI has received research support from NIH. The institution of Mary Reilly, MD, FRCP, FRCPI has received research support from MDA.
Stefan A. Dupont, MD, PhD No disclosure on file
Elliot M. Frohman, MD, FAAN Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date. Dr. Frohman has received publishing royalties from a publication relating to health care.
Alexander U. Brandt, MD No disclosure on file
Thomas Meier, PhD No disclosure on file
Mark Stacy, MD Dr. Stacy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biovie. Dr. Stacy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for National Institute of Aging. Dr. Stacy has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Dartmouth. Dr. Stacy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Journal.
Joanne Festa, PhD No disclosure on file
Jens Wuerfel, MD Dr. Wuerfel has received personal compensation for serving as an employee of MIAC AG. The institution of Dr. Wuerfel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Actelion. The institution of Dr. Wuerfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Wuerfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Gina Remington No disclosure on file
Cheryl A. Palmer, MD No disclosure on file
Cornelia Laule, PhD The institution of Dr. Laule has received research support from Multiple Sclerosis Society of Canada. The institution of Dr. Laule has received research support from Natural Sciences and Engineering Research Council of Canada (NSERC). The institution of Dr. Laule has received research support from International Collaboration on Repair Discoveries (ICORD).
Angela B. Deutschlander, MD No disclosure on file
Qi Rui Yang, MD, PhD No disclosure on file
Ashish Nanda, MD No disclosure on file
Dorene M. Rentz, PsyD Dr. Rentz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Digital Cognition Technologies. Dr. Rentz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurotrack.
Qing Hao, MD No disclosure on file
Alfredo Firstenfeld, MD No disclosure on file
James E. Galvin, MD, MPH Dr. Galvin has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cognivue. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Biogen. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eisai. Dr. Galvin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Galvin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GE Healthcare. Dr. Galvin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Galvin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PassageBio. The institution of Dr. Galvin has received research support from National Institutes of Health. Dr. Galvin has received intellectual property interests from a discovery or technology relating to health care. Dr. Galvin has a non-compensated relationship as a Board of Directors with Alzheimer Association Southeast Florida Chapter that is relevant to AAN interests or activities. Dr. Galvin has a non-compensated relationship as a Board of Directors with Lewy Body Dementia Association that is relevant to AAN interests or activities. Dr. Galvin has a non-compensated relationship as a Board of Directors with Lewy Body Dementia Resource Center that is relevant to AAN interests or activities.
Nuwan Kurukulasuriya, PhD No disclosure on file
Roberto Sica, MD, PhD No disclosure on file
Luigi M. Specchio No disclosure on file
Ji Hoe Heo, MD, PhD No disclosure on file
Karin G. Johnson, MD, FAAN Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RealCME. Dr. Johnson has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Save Standard Time. The institution of Dr. Johnson has received research support from Apnimed.
Gerald Wiest, MD, FAAN No disclosure on file
Mikael Cohen Mikael Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Roche, Merck, Ad scientiam, Novartis, Alexion, BMS.
Gisella Gargiulo Monachelli, MD, PhD No disclosure on file
Jeffrey A. Kaye, MD, FAAN Dr. Kaye has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Kaye has stock in Life Analytics. The institution of Dr. Kaye has received research support from NIH. The institution of Dr. Kaye has received research support from NSF. The institution of Dr. Kaye has received research support from AbbVie. Dr. Kaye has received intellectual property interests from a discovery or technology relating to health care.
Divya Gupta, MD No disclosure on file
Urzula Chyrchel, PhD No disclosure on file
Michael Strupp, MD, DO, FAAN Dr. Strupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertify. Dr. Strupp has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for IntraBio. Dr. Strupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vifor, Frisenius, CH. Dr. Strupp has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Strupp has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers. Dr. Strupp has or had stock in IntraBio.
Matthew Jensen, MD No disclosure on file
Katherine Treadaway, LCSW No disclosure on file
Halina Bartosik-Psujek No disclosure on file
Raul C. Rey, MD No disclosure on file
Michael S. Vaphiades, DO No disclosure on file
Mauro Comola No disclosure on file
Srivadee Oravivattanakul, MD Dr. Oravivattanakul has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva.
Wojtck Ambrosius, MD, PhD No disclosure on file
Rema Raman, PhD No disclosure on file
Eng Lo, MD Eng Lo, MD has nothing to disclose.
Richard P. Allen, PhD No disclosure on file
Nirit Lev, MD No disclosure on file
Melanie McNally, MD No disclosure on file
Eroboghene E. Ubogu, MD, MBBS No disclosure on file
Gregory N. Barnes, MD, PhD No disclosure on file
Tracy Chiem, MD No disclosure on file
Kristin Jack, MD No disclosure on file
Bing-Wen Soong, MD, PhD, FAAN No disclosure on file
Christian Denier No disclosure on file
Anthony Polazzo No disclosure on file
Ricardo F. Allegri, MD, PhD, FAAN Dr. Allegri has nothing to disclose.
Yuji Tanaka, MD, PhD No disclosure on file
Haitham Hussein, MD, FAAN Dr. Hussein has nothing to disclose.
Ameer Hassan, DO Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stryker. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Penumbra. Dr. Hassan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerenovus. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Viz.ai. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Hassan has received research support from GE Healthcare.
Lawrence Marinucci No disclosure on file
Muhammad W. Anjum, MD Dr. Anjum has nothing to disclose.
Cory C. Toth, MD No disclosure on file
R. John Leigh, MD No disclosure on file
Anil K. Nair, MD, FAAN No disclosure on file
Katrin Gross-Paju, MD, PhD Dr. Gross-Paju has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Gross-Paju has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Gross-Paju has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck.
Barbara E. Tettenborn, MD No disclosure on file
Adam MacLellan, MD, BSch No disclosure on file
Zeki Odabasi No disclosure on file
Martin Gizzi, MD, PhD, FAAN No disclosure on file
Harsh Aggarwal, MD No disclosure on file
John Scagnelli, MD The institution of Dr. Scagnelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Scagnelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Scagnelli has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen IDEC. The institution of Dr. Scagnelli has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Scagnelli has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for NC Neurologic Society.
Richard E. Temes, MD No disclosure on file
Wieslaw J. Oczkowski, MD Dr. Oczkowski has nothing to disclose.
Douglas Galasko, MD Dr. Galasko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly, Inc. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Diagnostics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognition THeraprutics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Artery Therapeutics.
Eldad Melamed, MD No disclosure on file
Leo Wolansky, MD The institution of Dr. Wolansky has received research support from Guerbet.
Geetha Chari, MD, FAAN Dr. Chari has nothing to disclose.
Muhammad S. Hussain, MD Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiger Medical.
Christopher L. Songster No disclosure on file
Takashi Inuzuka, MD, FAAN No disclosure on file
Andrew D. Siderowf, MD Dr. Siderowf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer-Ingelheim. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for askbio. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for capsida. Dr. Siderowf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Parkinson Study Group. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theravance. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prilenia. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurogastrix. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alerity. Dr. Siderowf has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clintrex. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. Dr. Siderowf has a non-compensated relationship as a Scientific Advisory Board with NeuroPacs that is relevant to AAN interests or activities.
Stacy Michalski No disclosure on file
Aniel Q. Majjhoo, MD, FAAN No disclosure on file
Eduardo D. Zamora, MD No disclosure on file
Pablo A. Celnik, MD No disclosure on file
Gustavo J. Rodriguez, MD Dr. Rodriguez has nothing to disclose.
Yoshio Tsuboi, MD Dr. Tsuboi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai Co., Ltd.,. Dr. Tsuboi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda Pharmaceutical Co., Ltd.,. Dr. Tsuboi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sumitomo Dainippon Pharma Co., Ltd.. Dr. Tsuboi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie GK,. Dr. Tsuboi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Otsuka Pharmaceutical Co., Ltd.. Dr. Tsuboi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin Co., Ltd.. The institution of Dr. Tsuboi has received research support from Nipro Corporation.
Shlomit Yust-Katz, MD Dr. Yust-Katz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for pfizer. Dr. Yust-Katz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Organon. Dr. Yust-Katz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. The institution of Dr. Yust-Katz has received research support from MERK.
Maria Rosa Rottoli, MD No disclosure on file
Marco Chiarini No disclosure on file
Robert A. Gross, MD, PhD, FAAN Dr. Gross has received publishing royalties from a publication relating to health care.
Janet C. Rucker, MD Dr. Rucker has nothing to disclose.
Tanuja Chitnis, MD, FAAN Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Sherry Hsiang-Yi Chou, MD Dr. Hsiang-Yi Chou has received personal compensation for serving as an employee of NIH. An immediate family member of Dr. Hsiang-Yi Chou has received personal compensation for serving as an employee of Wells Fargo. Dr. Hsiang-Yi Chou has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Grace Therapeutics. The institution of Dr. Hsiang-Yi Chou has received research support from The Neurocritical Care Society. Dr. Hsiang-Yi Chou has a non-compensated relationship as a Board of Director member with United Council of Neurologic Specialties that is relevant to AAN interests or activities. Dr. Hsiang-Yi Chou has a non-compensated relationship as a Co-chair/chair-elect, the Neurocritical Care Committee with American Heart Association, the Stroke Council that is relevant to AAN interests or activities. Dr. Hsiang-Yi Chou has a non-compensated relationship as a Co-chair/chair ellect, the Neurocritical Care Special Interest Group with American Neurologic Association that is relevant to AAN interests or activities.
Ron Cohen, MD Dr. Cohen has received personal compensation for serving as an employee of Acorda Therapeutics. Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for VBL Therapeutics. Dr. Cohen has stock in Acorda Therapeutics.
Andrew M. Naidech, MD, FAAN Dr. Naidech has received publishing royalties from a publication relating to health care.
Ambooj Tiwari, MD Dr. Tiwari has nothing to disclose.
Mohammad Moussavi, MD Dr. Moussavi has nothing to disclose.
Thomas Wychowski, MD The institution of Dr. Wychowski has received research support from UCB.
Adi Vaknin-Dembinsky, MD Dr. Vaknin-Dembinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medison Pharma. Dr. Vaknin-Dembinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for neopharm group. Dr. Vaknin-Dembinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for medisone . Dr. Vaknin-Dembinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for alexion.
Martina Vendrame, MD PhD Dr. Vendrame has nothing to disclose.
Federico Serana No disclosure on file
G.R. Wayne Moore, MD The institution of Dr. Moore has received research support from MS Canada.
Pradeep Banerjee, PhD No disclosure on file
Ryuji Neshige No disclosure on file
Jawad F. Kirmani, MD Dr. Kirmani has nothing to disclose.
Kevin F. Haas, MD, PhD No disclosure on file
Todd D. Rozen, MD, FAAN No disclosure on file
David P. Salmon, PhD Dr. Salmon has nothing to disclose.
Douglas S. Goodin, MD No disclosure on file
Morris Levin, MD, FAAN Dr. Levin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus, Upsher Smith, Biohaven, Revance, Percept, Theranica, Allergan, Alder, Currax. Dr. Levin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Levin has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific. Dr. Levin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Attorney . Dr. Levin has received stock or an ownership interest from Percept. Dr. Levin has received publishing royalties from a publication relating to health care.
Andrew Blight, PhD No disclosure on file
Massimo Filippi, MD, FAAN Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Brian J. Murray, MD, FAAN The institution of Dr. Murray has received research support from Wake Up Narcolepsy. Dr. Murray has received publishing royalties from a publication relating to health care.
Michael G. Dwyer III, MD, PhD Dr. Dwyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Keystone Heart, Ltd. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Dwyer has received research support from Novartis. The institution of Dr. Dwyer has received research support from Keystone Heart, Ltd. The institution of Dr. Dwyer has received research support from Bristol Myers Squibb. The institution of Dr. Dwyer has received research support from Roche.
Ricardo Ginestal, MD No disclosure on file
Cathy A. Sila, MD, FAAN Dr. Sila has nothing to disclose.
Linda A. Hershey, MD, PhD, FAAN Dr. Hershey has received personal compensation for serving as an employee of 好色先生. Dr. Hershey has received personal compensation for serving as an employee of MedLink Neurology LLC. Dr. Hershey has received personal compensation for serving as an employee of American College of Physicians. Dr. Hershey has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. An immediate family member of Dr. Hershey has stock in Diverse portfolio.
Dimitrios Karussis, MD, PhD Prof. Karussis has nothing to disclose.
Monica K. Crane, MD Dr. Crane has received personal compensation for serving as an employee of Tennessee Memory Disorders Foundation/ Genesis Neuroscience Clinic. An immediate family member of Dr. Crane has received personal compensation for serving as an employee of Knoxville Orthopedic Clinic. Dr. Crane has received research support from Provision - Center for Biomedical Research.
Edward Keller No disclosure on file
Kwang-Dong Choi, MD No disclosure on file
Tracey A. Milligan, MD, FAAN Dr. Milligan has received publishing royalties from a publication relating to health care.
Edward J. Fine, MD, FAAN Dr. Fine has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Friends of PALS (People with ALS.
Jun-ichi Satoh, MD, PhD No disclosure on file
Yu-Tze Ng, MD, FRACP, FAAN No disclosure on file
Brian C. Healy The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Ramandeep Sahni, MD Dr. Sahni has nothing to disclose.
Michael Schroeter No disclosure on file
Dan J. Capampangan, MD, FAAN No disclosure on file
Mustapha A. Ezzeddine, MD, FAAN The institution of Dr. Ezzeddine has received research support from NIH.
Muhammad F. Suri, MD Dr. Suri has nothing to disclose.
Subasini Dash, MD No disclosure on file
Derrick Blackmore No disclosure on file
Richard J. Lederman, MD, PhD, FAAN No disclosure on file
Bart Demaerschalk, MD, MSc, FRCPC, FAAN Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Demaerschalk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Neurologist . The institution of Dr. Demaerschalk has received research support from NICHD.
Philip H. Schwartz, PhD No disclosure on file
Zaeem A. Siddiqi, MD, PhD Dr. Siddiqi has nothing to disclose.
Jeffrey C. Looi, MD No disclosure on file
Jesus Porta-Etessam No disclosure on file
Vineet Punia, MD Dr. Punia has nothing to disclose.
James L. Frey, MD, FAAN No disclosure on file
Isao Hozumi, MD, PhD No disclosure on file
Sarah H. Ying, MD Dr. Ying has nothing to disclose.
Steve M. Cordina, MD, FAAN Dr. Cordina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Microvention. Dr. Cordina has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech .
Jorge Asconape, MD Dr. Asconape has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Asconape has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Lifesciences.
Geoffrey J. Arlt, MD No disclosure on file
Basanagoud Mudigoudar, MD Dr. Mudigoudar has nothing to disclose.
Neha Dangayach, MD, FAAN Dr. Dangayach has nothing to disclose.
Andrea Falini No disclosure on file
Rocco Totaro, MD No disclosure on file
Xin Wang, MD No disclosure on file
Donald G. Brunet, MD No disclosure on file
Johanna L. Morton, MD, MS Dr. Morton has received personal compensation for serving as an employee of SOC Telemed. Dr. Morton has received personal compensation for serving as an employee of The Joint Commission.
Roberta Fantozzi, MD No disclosure on file
Raffaella Clerici, MD No disclosure on file
Clementine Karageorgiou, MD The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for GENESIS PHARMA. The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for TEVA-SPECIFAR.
Oded Abramsky, MD, PhD, FAAN No disclosure on file
Han Jin Cho No disclosure on file
Van Halbach, MD No disclosure on file
Charlene Gamaldo, MD, FAAN Dr. Gamaldo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for johns hopkins. Dr. Gamaldo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. Dr. Gamaldo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Gamaldo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Apnimed. The institution of Dr. Gamaldo has received research support from NIH/NIMH/NIDA/NINDS. Dr. Gamaldo has received publishing royalties from a publication relating to health care.
William D. Arnold, MD Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for La Hoffmann Roche. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadent Therapeutics . Dr. Arnold has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Arnold has received research support from NIH. The institution of Dr. Arnold has received research support from NMD Pharma. The institution of Dr. Arnold has received research support from Gilead Sciences. The institution of Dr. Arnold has received research support from CureSMA. Dr. Arnold has received intellectual property interests from a discovery or technology relating to health care.
Michael J. Strong, MD, FAAN No disclosure on file
Keith R. Edwards, MD, FAAN No disclosure on file
Emmanuel Roze, MD, PhD Dr. Roze has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for merz. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving as a Consultant for orkyn. Dr. Roze has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for elivie. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for allergan. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Orkyn. Dr. Roze has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for elivie. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aguettant. The institution of Dr. Roze has received research support from merz. The institution of Dr. Roze has received research support from Orkyn. Dr. Roze has received research support from elivie. The institution of Dr. Roze has received research support from allergan. The institution of Dr. Roze has received research support from fondation desmarest. The institution of Dr. Roze has received research support from everpharma. Dr. Roze has received research support from AMADYS. The institution of Dr. Roze has received research support from ADCY5.org. The institution of Dr. Roze has received research support from agence nationale de la recherche. The institution of Dr. Roze has received research support from société française de médecine esthétique. The institution of Dr. Roze has received research support from dystonia medical research foundation.
Steven K. Feske, MD Dr. Feske has received publishing royalties from a publication relating to health care.
David D. Adams David D. Adams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ALNYLAM. David D. Adams has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer.
Randall T. Schapiro, MD, FAAN No disclosure on file
Michael J. Marmura, MD, FAAN Dr. Marmura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Marmura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. The institution of Dr. Marmura has received research support from Teva. The institution of Dr. Marmura has received research support from AbbVie. The institution of Dr. Marmura has received research support from Axsome. The institution of Dr. Marmura has received research support from Pfizer. Dr. Marmura has received publishing royalties from a publication relating to health care. Dr. Marmura has received publishing royalties from a publication relating to health care. Dr. Marmura has received publishing royalties from a publication relating to health care.
Flavia Nelson, MD Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Brystol Meyer Squib. Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Nelson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genetech. The institution of Dr. Nelson has received research support from NIH. Dr. Nelson has received research support from Novartis.
Mahmoud Rayes, MD No disclosure on file
Shyam Prabhakaran, MD Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. The institution of Dr. Prabhakaran has received research support from NIH . The institution of Dr. Prabhakaran has received research support from AHRQ. Dr. Prabhakaran has received publishing royalties from a publication relating to health care.
Kamala Saha, MD, FAAN Dr. Saha has nothing to disclose.
Gianfranco Costantino, MD No disclosure on file
Athanasia Alexoudi, MD Dr. Alexoudi has nothing to disclose.
Aurora Fuiani, MD No disclosure on file
Augusto Morales, MD No disclosure on file
Panayiota Petrou No disclosure on file
Donald Johns, MD No disclosure on file
Julie A. Khoury, MD Dr. Khoury has nothing to disclose.
Philip De Jager, MD, PhD Dr. De Jager has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Puretech. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. The institution of Dr. De Jager has received research support from roche. The institution of Dr. De Jager has received research support from puretech.
Yi-Chung Lee, MD, FAAN The institution of Dr. Lee has received research support from National Science and technology Council Taiwan . The institution of Dr. Lee has received research support from Taipei Veterans General Hospital Taiwan.
Lysa Boissé Lomax, MD Dr. Boissé Lomax has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Boissé Lomax has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB, Eisai, Sunovion. Dr. Boissé Lomax has received personal compensation in the range of $0-$499 for serving as an Expert Witness for Correctional Service Canada. The institution of Dr. Boissé Lomax has received research support from UCB.
Matt T. Bianchi, MD, PhD No disclosure on file
Ruggero Capra, MD Dr. Capra has nothing to disclose.
Eric Russell, MD No disclosure on file
Ari Green, MD Dr. Green has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Green has received research support from Department of Defense. The institution of Dr. Green has received research support from Department of Defense. The institution of Dr. Green has received research support from NIH. The institution of Dr. Green has received research support from NIH / NINDS. The institution of Dr. Green has received research support from NIH / NINDS. Dr. Green has received intellectual property interests from a discovery or technology relating to health care.
Kenkichi Nozaki, MD No disclosure on file
Maria A. Rocca Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Luisa Imberti No disclosure on file
Rajeev Garg, MD, FAAN Dr. Garg has nothing to disclose.
Cecilia Serrano No disclosure on file
Marco Salvetti, MD Dr. Salvetti has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for sanofi. Dr. Salvetti has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. The institution of Dr. Salvetti has received research support from bms.
Patricia Musolino, MD, PhD An immediate family member of Dr. Musolino has received personal compensation for serving as an employee of EMD Sorono. Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Minoryx Pharmaceuticals. Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for IONIS Pharmaceuticals . Dr. Musolino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inozyme Pharma. Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex Pharmaceuticals. An immediate family member of Dr. Musolino has or had stock in 2seventy Bio. An immediate family member of Dr. Musolino has or had stock in Editas Medicine. An immediate family member of Dr. Musolino has or had stock in Generation Bio. An immediate family member of Dr. Musolino has or had stock in Beam Therapeutics. An immediate family member of Dr. Musolino has or had stock in Ebotec . An immediate family member of Dr. Musolino has or had stock in Novonordisk. An immediate family member of Dr. Musolino has or had stock in Morphosys. The institution of Dr. Musolino has received research support from National Institute of Health-NINDS-R01. The institution of Dr. Musolino has received research support from Angea Biotherapeutics. The institution of Dr. Musolino has received research support from Minoryx Pharmaceuticals. The institution of Dr. Musolino has received research support from Belanger Foundation. The institution of Dr. Musolino has received research support from Rozwat Family Foundation. The institution of Dr. Musolino has received research support from Dooley Family Foundation. Dr. Musolino has received intellectual property interests from a discovery or technology relating to health care. Dr. Musolino has received publishing royalties from a publication relating to health care.
Akash J. Patel No disclosure on file
Adam Spira No disclosure on file
Andrew A. Wong, MBBS, PhD, FAAN No disclosure on file
Terri J. Kiernan, NP No disclosure on file
Umit H. Ulas, MD No disclosure on file
Nicolaas I. Bohnen, MD, PhD, FAAN Dr. Bohnen has stock in Delta. The institution of Dr. Bohnen has received research support from NIH. The institution of Dr. Bohnen has received research support from VA. Dr. Bohnen has received research support from NIH. The institution of Dr. Bohnen has received research support from Parkinson fnd.
Ichizo Nishino, MD, PhD, FAAN The institution of Dr. Nishino has received research support from AMED.
Vincenzo Silani, MD, FAAN Dr. Silani has nothing to disclose.
John M. Bertoni, MD, PhD, FAAN Dr. Bertoni has nothing to disclose.
Leo H. Wang, MD, PhD, FAAN Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AskBio. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Fulcrum Therapeutics. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avidity. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lupin. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. The institution of Dr. Wang has received research support from National Institute of Health. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with US Government.
Rohan Arora, MD The institution of Dr. Arora has received research support from Bayer.
Philippe Robert, MD No disclosure on file
Varun V. Reddy, MD No disclosure on file
Elizabeth Thiele, MD Dr. Thiele has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GW Pharma/Jazz. Dr. Thiele has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for zogenix/UCB. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for nobelpharma. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for livanova. Dr. Thiele has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Noema Pharma. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for pyros pharmaceutical/upsher smith. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. The institution of Dr. Thiele has received research support from GW Pharma/Jazz. The institution of Dr. Thiele has received research support from Zogenix/UCB. The institution of Dr. Thiele has received research support from Stoke Therapeutics. The institution of Dr. Thiele has received research support from Biocodex. Dr. Thiele has received publishing royalties from a publication relating to health care.
Oleg Butovsky, PhD No disclosure on file
Marko Chatzopoulos, PhD No disclosure on file
Timothy Collier No disclosure on file
Serguei Pakhomov No disclosure on file
Lee H. Schwamm, MD, FAAN Dr. Schwamm has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Prime 好色先生. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Schwamm has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for lifeimage. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for mediasphere. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for medscape/WebMD. Dr. Schwamm has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for medtronic. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Penumbra. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Schwamm has received research support from NINDS. The institution of Dr. Schwamm has received research support from PCORI. Dr. Schwamm has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Schwamm has received publishing royalties from a publication relating to health care. Dr. Schwamm has a non-compensated relationship as a Board of directors with American heart association that is relevant to AAN interests or activities.
Sabrina Smith, MD, PhD No disclosure on file
Wouter Schievink, MD Dr. Schievink has nothing to disclose.
Jin Li, MD, PhD, FAAN Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Li has a non-compensated relationship as a member, woman leadership committee with AAN that is relevant to AAN interests or activities.
Stephen J. Marks, MD No disclosure on file
Andrew Xavier, MD No disclosure on file
Anabel R. Chade, MD No disclosure on file
Sandra R. Richman, MD No disclosure on file
Antonia Ratti, PhD No disclosure on file
Nicola Ticozzi, MD The institution of Dr. Ticozzi has received research support from Italian Ministry of Health . The institution of Dr. Ticozzi has received research support from AriSLA.
David J. Libon, PhD No disclosure on file
Thomas Brannagan III, MD, FAAN Dr. Brannagan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zenica. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. The institution of Dr. Brannagan has received research support from Alnylam. The institution of Dr. Brannagan has received research support from Abcuro. The institution of Dr. Brannagan has received research support from Ionis. The institution of Dr. Brannagan has received research support from Vertex. The institution of Dr. Brannagan has received research support from NMD Pharma.
Asif M. Paker, MD, MPH Dr. Paker has received personal compensation for serving as an employee of SwanBio Therapeutics.
Robert R. Coleman, MD Dr. Coleman has nothing to disclose.
Dimitrios Arkilo, MD Dr. Arkilo has received personal compensation for serving as an employee of Sage Therapeutics. Dr. Arkilo has received personal compensation for serving as an employee of Acadia Pharmaceuticals. Dr. Arkilo has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Arkilo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EcoR1. An immediate family member of Dr. Arkilo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. An immediate family member of Dr. Arkilo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medtronic. Dr. Arkilo has stock in Takeda Pharmaceuticals. Dr. Arkilo has stock in Acadia Pharmaceuticals. Dr. Arkilo has stock in Sage Therapeutics.
Enrique Alvarez, MD, PhD Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Fang Ba, MD Dr. Ba has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. The institution of Dr. Ba has received research support from Social Sciences and Humanities Research Council.
Peng R. Chen Peng R. Chen has nothing to disclose.
Michael Su, MD Dr. Su has nothing to disclose.
Andrew D. Barreto, MD No disclosure on file
Gian Marco De Marchis, MD No disclosure on file
Vivek Misra, MD Dr. Misra has nothing to disclose.
Lindsay Perry, DPT No disclosure on file
Gregoire Morisse, MSc No disclosure on file
Nicole Gonzales, MD The institution of Dr. Gonzales has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology.
Joel M. Trugman, MD, FAAN Dr. Trugman has received personal compensation for serving as an employee of AbbVie. Dr. Trugman has stock in AbbVie.
Sudhakar Tummala, MD, FAAN Dr. Tummala has nothing to disclose.
Daniel Jose Correa, MD, MSc, FAAN Dr. Correa has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. Dr. Correa has or had stock in Aidin Inc.Dr. Correa has received research support from Genentech. Dr. Correa has received research support from Psi Upsilon Foundation Inc.
Andrew B. Lassman, MD, FAAN No disclosure on file
Wayne W. Feng, MD, FAAN Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Namsa. The institution of Dr. Feng has received research support from NIH. The institution of Dr. Feng has received research support from American heart association . The institution of Dr. Feng has received research support from Ipsen.
Alona Muzikansky No disclosure on file
Ludwig Kappos, MD, FAAN Dr. Kappos has nothing to disclose.
Barbara G. Vickrey, MD, MPH, FAAN The institution of Dr. Vickrey has received research support from NIH. Dr. Vickrey has received personal compensation in the range of $0-$499 for serving as a Grant reviewer, committee co-chair with NIH. Dr. Vickrey has received personal compensation in the range of $0-$499 for serving as a conference advisory committee with University of Rochester. Dr. Vickrey has a non-compensated relationship as a Second Vice President with Association of University Professors of Neurology that is relevant to AAN interests or activities. Dr. Vickrey has a non-compensated relationship as a Nominating Committee member of Stroke Council with American Heart Association that is relevant to AAN interests or activities. Dr. Vickrey has a non-compensated relationship as a Nominating Committee Chair with American Neurological Association that is relevant to AAN interests or activities.
Jerry S. Wolinsky, MD, FAAN Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cleveland Clinic Foundation. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inmagene. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis/Sandoz. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Alabama Birmingham. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care.
Adam L. Boxer, MD, PhD An immediate family member of Dr. Boxer has received personal compensation for serving as an employee of Kaiser Permanente. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Oscotec. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arrowhead. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine Biosciences. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Switch. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvinas. Dr. Boxer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alector. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Boxer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Transposon. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Boxer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Boxer has stock in Alector. Dr. Boxer has stock in Arvinas. Dr. Boxer has stock in Neurovanda. The institution of Dr. Boxer has received research support from Biogen. The institution of Dr. Boxer has received research support from Eisai. The institution of Dr. Boxer has received research support from Regeneron. The institution of Dr. Boxer has received research support from NIH. The institution of Dr. Boxer has received research support from Bluefield Project-5. Dr. Boxer has received research support from Rainwater Charitable Foundation. Dr. Boxer has received research support from GHR Foundation. Dr. Boxer has received intellectual property interests from a discovery or technology relating to health care.
Pierre Clavelou, MD, PhD Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Nazli A. Janjua, MD, MBBS Dr. Janjua has nothing to disclose.
Cinzia Gellera, MD No disclosure on file
Richard A. Rudick, MD, FAAN Dr. Rudick has received personal compensation for serving as an employee of Biogen. Dr. Rudick has received stock or an ownership interest from Biogen. Dr. Rudick has received publishing royalties from a publication relating to health care.
Manpreet Kaur, MD No disclosure on file
R. Michael Gendreau No disclosure on file
David C. Tong, MD, FAHA No disclosure on file
Joshua Grill, PhD No disclosure on file
Marc W. Slutzky, MD, PhD, FAAN No disclosure on file
K. Nicole Mims, MD No disclosure on file
Maria C. Polidori, MD No disclosure on file
Benjamin D. Schanker No disclosure on file
Mark Obermann, MD, FAAN No disclosure on file
Bob Bucelli, MD, PhD Dr. Bucelli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen . Dr. Bucelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Bucelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Bucelli has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Hamilton Weber. Dr. Bucelli has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for O'Bryan Brown and Toner. Dr. Bucelli has stock in Neuroquestions.com. An immediate family member of Dr. Bucelli has stock in Neuroquestions.com. The institution of Dr. Bucelli has received research support from Biogen. The institution of Dr. Bucelli has received research support from Ionis.
Gordon S. Francis, MD, FAAN No disclosure on file
Sathyanath Rajasekharan, PhD No disclosure on file
Carmen Bozic, MD No disclosure on file
Stefania Corti, MD, PhD Dr. Corti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Corti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Corti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta.
Amit Kansara, MD Dr. Kansara has nothing to disclose.
Douglas R. Jeffery, MD, PhD No disclosure on file
Shirley Chen, DO No disclosure on file
William Collins No disclosure on file
Joon Hyun Shin, MD No disclosure on file
Raghav Govindarajan, MD, FAAN Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Michelle Greer No disclosure on file
Krupa S. Pandey, MD Dr. Pandey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Pandey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. Dr. Pandey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech . Dr. Pandey has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. Dr. Pandey has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen . Dr. Pandey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech . Dr. Pandey has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Horizon Therapeutics . The institution of Dr. Pandey has received research support from NIH. The institution of Dr. Pandey has received research support from CMSC.
Vanessa Dimayuga No disclosure on file
Vernon D. Rowe, MD, FAAN No disclosure on file
Man-Wook Seo, MD, PhD No disclosure on file
James C. Grotta, MD, FAAN Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Frazer Ltd. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Haemonetics. Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acticor. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prolong Pharma. Dr. Grotta has received publishing royalties from a publication relating to health care. Dr. Grotta has received publishing royalties from a publication relating to health care.
Amy L. Phillips, PharmD Amy L. Phillips, PharmD has received personal compensation for serving as an employee of EMD Serono, Inc.
Tomonobu Kato No disclosure on file
Howard S. Kirshner, MD, FAAN No disclosure on file
Gretchen A. Ayer, MS No disclosure on file
Toby I. Gropen, MD Dr. Gropen has nothing to disclose.
Beth Ann Ward, MD No disclosure on file
Dana M. Winegarner, DO No disclosure on file
Walter C. Low, PhD No disclosure on file
Reshma Gokaldas, MD No disclosure on file
Elizabeth Waterhouse, MD, FAAN Dr. Waterhouse has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Waterhouse has received research support from Xenon.
Michelle Cameron, MD Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich Biosciences/Jazz . Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Adamas Pharmaceuticals. Dr. Cameron has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Cameron has received research support from National MS Society. The institution of Dr. Cameron has received research support from Department of Veterans Affairs. Dr. Cameron has received publishing royalties from a publication relating to health care.
Jonathan Newmark, MD, MM, FAAN Dr. Newmark has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Integrum BioSciences.
Christophe Hotermans, MD, PhD No disclosure on file
Ramy El Khoury, MD, FAAN No disclosure on file
nobl barazangi, MD, PhD Dr. Barazangi has nothing to disclose.
Arun R. Antony, MD Dr. Antony has nothing to disclose.
Miguel E. Fiol-Elias, MD No disclosure on file
Max Krucoff No disclosure on file
Mercedes P. Jacobson, MD The institution of Dr. Jacobson has received research support from Engage. The institution of Dr. Jacobson has received research support from XENON. The institution of Dr. Jacobson has received research support from SK Life Sciences.
Jonathan K. Smith, MD, FAAN Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for OBT Law. Dr. Smith has a non-compensated relationship as a Committee Member, Clinical Neurophysiology CMOC Pilot, with ABPN that is relevant to AAN interests or activities.
Vicki L. Wheelock, MD Dr. Wheelock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Pharmaceuticals. Dr. Wheelock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for uniQure. Dr. Wheelock has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PRIME Continuing Medical 好色先生.
Snehi Sehgal-Kapur, MD No disclosure on file
Shahram Majidi, MD Dr. Majidi has nothing to disclose.
Daphne Wang No disclosure on file
Beau M. Ances, MD, PhD, MS, FAAN Dr. Ances has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH.
Heinrich P. Mattle, MD No disclosure on file
Jack C. Rose, MD No disclosure on file
Mushtaq H. Qureshi, MD No disclosure on file
Rebbeca Grysiewicz, DO No disclosure on file
Sophia S. Lee, PhD No disclosure on file
Tammie Benzinger Tammie Benzinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Tammie Benzinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Tammie Benzinger has received personal compensation in the range of $0-$499 for serving as a Consultant for Sora Neuroscience. Tammie Benzinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Tammie Benzinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Tammie Benzinger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Tammie Benzinger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Tammie Benzinger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol, Myers Squibb. Tammie Benzinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for PeerView. Tammie Benzinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medscape. The institution of Tammie Benzinger has received research support from Siemens. The institution of Tammie Benzinger has received research support from Hyperfine. Tammie Benzinger has a non-compensated relationship as a Consultant with Siemens that is relevant to AAN interests or activities. Tammie Benzinger has a non-compensated relationship as a Consultant with Eisai that is relevant to AAN interests or activities.
Amrou Sarraj, MD Dr. Sarraj has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Dr. Sarraj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker Neurovascular. Dr. Sarraj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Stryker Neurovascular. The institution of Dr. Sarraj has received research support from Stryker Neurovascular.
Danielle Gordon, MD Dr. Gordon has nothing to disclose.
Michael Sweeney, MD No disclosure on file
Judith Haas, MD No disclosure on file
Lisa D. Hermann, MD Dr. Hermann has nothing to disclose.
Joel Kramer, PhD The institution of Dr. Kramer has received research support from tau consortium. Dr. Kramer has received publishing royalties from a publication relating to health care.
Fawn Leigh, MD No disclosure on file
Jack H. Jhamandas, MD, PhD No disclosure on file
Peter A. Ljubenkov, MD Dr. Ljubenkov has nothing to disclose.
Arthur D. Forman, MD No disclosure on file
Rammohan V. Maikala, DO No disclosure on file
Emmanuel Mulin No disclosure on file
Takuya Yagi No disclosure on file
Preeti Sahota, MD No disclosure on file
Gereon Nelles, MD, PhD, FAAN Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Industry. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Memodio. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Industrial. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Industry. Dr. Nelles has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Industry. Dr. Nelles has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for German Neurologists Professional Organization. Dr. Nelles has received publishing royalties from a publication relating to health care.
Janice Wong, MD Dr. Wong has received personal compensation for serving as an employee of Janssen Research & Development. Dr. Wong has received personal compensation for serving as an employee of Biogen. Dr. Wong has stock in Biogen. Dr. Wong has stock in Janssen Research & Development.
Giuseppe Lanzino, MD Dr. Lanzino has nothing to disclose.
Aekaterini Galimanis No disclosure on file
Sonya G. Wang, MD Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ovid Therapeutics.
Huijun Wang, MD, PhD No disclosure on file
Gregory Kapinos, MD, MS No disclosure on file
Gary Bloomgren, MD, MBA No disclosure on file
Sirisha Sanamandra, MBBS Dr. Sanamandra has nothing to disclose.
Laura A. Kalayjian, MD The institution of Dr. Kalayjian has received research support from NIH.
Maria P. Amato, PhD Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOU Careggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi genzyme. The institution of Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene BMS. The institution of Dr. Amato has received research support from Merck. The institution of Dr. Amato has received research support from Biogen. The institution of Dr. Amato has received research support from Roche.
Stephen Weigand Stephen Weigand has nothing to disclose.
Rima Alkasem, MD No disclosure on file
Oh Sun-Young, MD, PhD No disclosure on file
Chih-Chao Yang, MD No disclosure on file
Victoria S. Wong, MD, FAAN No disclosure on file
Renaud David No disclosure on file
Eric E. Smith, MD Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. Dr. Smith has received publishing royalties from a publication relating to health care. Dr. Smith has received publishing royalties from a publication relating to health care.
John M. Pellock, MD No disclosure on file
Daria A. Trojan, MD No disclosure on file
Anthony Reder, MD Dr. Reder has nothing to disclose.
J. Americo M. Fernandes, Jr., MD, FAAN Dr. Fernandes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Columbia University. The institution of Dr. Fernandes has received research support from MGH philanthropy (Clene, Seelos, UCB, Biohaven, Prilenia, Denali Therapeutics, Calico Life Sciences. The institution of Dr. Fernandes has received research support from Columbia University. The institution of Dr. Fernandes has received research support from PTC Therapeutics. The institution of Dr. Fernandes has received research support from Clene.
Jasmina Ivanova No disclosure on file
Carlos S. Kase, MD, FAHA, FAAN Dr. Kase has nothing to disclose.
Steffen Naegel, MD No disclosure on file
Kazim A. Sheikh, MD The institution of Dr. Sheikh has received research support from NIH. The institution of Dr. Sheikh has received research support from DoD.
H. C. Diener, MD, FAAN Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Diener has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme. The institution of Dr. Diener has received research support from German Research Council.
Divisha Raheja, MD, FAAN Dr. Raheja has nothing to disclose.
Jeanne Ceballos, NP No disclosure on file
Sungpil Han No disclosure on file
Stuart Levine, MD No disclosure on file
April A. Erwin, MD Dr. Erwin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Erwin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Erwin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Celgene. Dr. Erwin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Erwin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Erwin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Erwin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Erwin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Erwin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol-Myers Squibb. The institution of Dr. Erwin has received research support from Genentech. The institution of Dr. Erwin has received research support from Abbvie. The institution of Dr. Erwin has received research support from Novartis. The institution of Dr. Erwin has received research support from Biogen.
Gary Hunter, MD No disclosure on file
Jung Hwa Lee, MD Dr. Lee has nothing to disclose.
Santiago Pigretti No disclosure on file
Viet Nguyen, MD Dr. Nguyen has received personal compensation for serving as an employee of Biogen. Dr. Nguyen has stock in Biogen.
Tonette Gehrking Tonette Gehrking has nothing to disclose.
James F. Burke, MD Dr. Burke has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association/Circulation: Cardiovascular quality and outcomes. The institution of Dr. Burke has received research support from Genentech Foundation. The institution of Dr. Burke has received research support from NIH.
So Young Moon, MD No disclosure on file
Hilde Henon No disclosure on file
Anthony L. Ritaccio, MD, FAAN The institution of Dr. Ritaccio has received research support from NIH. Dr. Ritaccio has received intellectual property interests from a discovery or technology relating to health care.
Andrew M. Chancellor, MD, FRACP No disclosure on file
Elisa Rubino, MD No disclosure on file
Ilham Slassi Sennou, MD No disclosure on file
Nicholas Blondin, MD Dr. Blondin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure, Inc.. Dr. Blondin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novocure, Inc..
Eric V. Hastriter, MD No disclosure on file
Khan Farid No disclosure on file
Yasser M. Awaad, MD No disclosure on file
Elizabeth Macri, MD Dr. Macri has nothing to disclose.
Saqib A. Chaudhry, MD Dr. Chaudhry has nothing to disclose.
Seongmin Choi, MD No disclosure on file
Nhu T. Bruce, MD No disclosure on file
Conrad Liang, MD Dr. Liang has nothing to disclose.
Steve W. Han, MD PhD No disclosure on file
Bernard F. Michel, MD No disclosure on file
Giovana Femat, MD No disclosure on file
Lisa McLean No disclosure on file
Cho Soo-Jin Cho Soo-Jin has nothing to disclose.
John Waterston, MD, MBBS, FRACP No disclosure on file
Adam Loavenbruck, MD Dr. Loavenbruck has nothing to disclose.
Osvaldo J. Nascimento, MD, PhD, FAAN Dr. Nascimento has nothing to disclose.
Senda Ajroud-Driss, MD, FAAN Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astrazeneca. Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Ajroud-Driss has received research support from NIH. The institution of Dr. Ajroud-Driss has received research support from University of Minesota/FDA. The institution of Dr. Ajroud-Driss has received research support from Edgewise Therapeutics. The institution of Dr. Ajroud-Driss has received research support from Biogen. The institution of Dr. Ajroud-Driss has received research support from Woolsey Pharmaceuticals. The institution of Dr. Ajroud-Driss has received research support from Uniqure Biopharma. The institution of Dr. Ajroud-Driss has received research support from Coya Therapeutics. The institution of Dr. Ajroud-Driss has received research support from Novartis. The institution of Dr. Ajroud-Driss has received research support from Alnylam pharmaceuticals. The institution of Dr. Ajroud-Driss has received research support from Healey and AMG center for ALS . The institution of Dr. Ajroud-Driss has received research support from les Turner ALS Foundation. The institution of Dr. Ajroud-Driss has received research support from Hopewell. The institution of Dr. Ajroud-Driss has received research support from Peripheral neuropathy foundation. Dr. Ajroud-Driss has received publishing royalties from a publication relating to health care.
Arash Salardini, MBBS Dr. Salardini has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. The institution of Dr. Salardini has received research support from NIH/NIA. The institution of Dr. Salardini has received research support from Taylor Family. Dr. Salardini has received publishing royalties from a publication relating to health care.
Stuart S. Mossman, MD No disclosure on file
Ki H. Cho, MD, PhD No disclosure on file
Laura Guilhoto, MD No disclosure on file
Patricio Brand, MD Dr. Brand has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Noam Harel, MD, PhD Dr. Harel has received personal compensation for serving as an employee of James J. Peters VA Medical Center. Dr. Harel has received personal compensation for serving as an employee of Icahn School of Medicine at Mount Sinai. Dr. Harel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for RubiconMD. Dr. Harel has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Dalton & Finegold, LLP. The institution of Dr. Harel has received research support from NIH. The institution of Dr. Harel has received research support from Craig H. Neilsen Foundation. The institution of Dr. Harel has received research support from New York State Department of Health. The institution of Dr. Harel has received research support from VA Rehabilitation Research and Development. Dr. Harel has a non-compensated relationship as a Neurology Editorial Board Member with AAN that is relevant to AAN interests or activities. Dr. Harel has a non-compensated relationship as a Member, Board of Directors with American Society of Neurorehabilitation that is relevant to AAN interests or activities. Dr. Harel has a non-compensated relationship as a Chair, AAN Spine Section with AAN that is relevant to AAN interests or activities.
Hideki Mochizuki, MD No disclosure on file
Randall L. Woltjer Randall L. Woltjer has nothing to disclose.
Stanton B. Elias, MD No disclosure on file
Jana Preiningerova, MD No disclosure on file
Solene Moulin No disclosure on file
Francisco A. Rodriguez Leal, MD Dr. Rodriguez Leal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Rodriguez Leal has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Dr. Rodriguez Leal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen.
Ariel L. Miller, MD, PhD Dr. Miller has nothing to disclose.
Lesli E. Skolarus, MD, MS The institution of Dr. Skolarus has received research support from NIH.
Myeong-Kyu Kim No disclosure on file
Michel P. Rathbone, MD, PhD No disclosure on file
Imad M. Najm, MD Dr. Najm has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai Inc. Dr. Najm has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Inc. Dr. Najm has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai Inc.
Gerwin Schalk, PhD No disclosure on file
April L. McVey, MD No disclosure on file
Mirela Cerghet, MD, PhD, FAAN Dr. Cerghet has nothing to disclose.
Peter Brunner No disclosure on file
Tesfaye Zelleke, MD No disclosure on file
Thomas M. Bosley, MD, FAAN No disclosure on file
Innocenzo Rainero, MD, PhD No disclosure on file
Andrew M. Blumenfeld, MD, FAAN Dr. Blumenfeld has received personal compensation for serving as an employee of The Los Angeles Headache Center. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctors. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GLG. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revance. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Axsome. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Axon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cedar Sinai. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AXSOME.
Amy Forst No disclosure on file
Rani A. Sarkis, MD, MSc The institution of Dr. Sarkis has received research support from NINDS.
Bhumsoo Kim No disclosure on file
Tae Sung Lim, MD No disclosure on file
Mei Jiang, MD No disclosure on file
Diana Richardson, MD No disclosure on file
Tai-Seung Nam, MD No disclosure on file
Norbert Roosen, MD No disclosure on file
Patrick D. Lyden, MD, FAAN Dr. Lyden has received personal compensation for serving as an employee of University of Southern Californiaq. Dr. Lyden has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Apex Innovations. Dr. Lyden has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various. The institution of Dr. Lyden has received research support from NINDS.
Delaram Safarpour, MD, MSCE, FAAN Dr. Safarpour has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 2nd MD. Dr. Safarpour has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Safarpour has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Safarpour has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Insightec. Dr. Safarpour has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BlueRock. Dr. Safarpour has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Safarpour has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific. The institution of Dr. Safarpour has received research support from Medtronic. The institution of Dr. Safarpour has received research support from Amneal. The institution of Dr. Safarpour has received research support from CND life science.
Olha Taraschenko, MD, PhD The institution of Dr. Taraschenko has received research support from NIH. The institution of Dr. Taraschenko has received research support from DHSS LB606 Nebraska Stem Cell Grant . Dr. Taraschenko has received personal compensation in the range of $0-$499 for serving as a Speaker with AES.
Elaine Roger No disclosure on file
Martin Donadio, MD No disclosure on file
Ashwani Joshi, MD No disclosure on file
Bijal M. Mehta, MD Dr. Mehta has nothing to disclose.
Vicente J. Iragui-Madoz, MD, PhD No disclosure on file
Vesna V. Brinar, MD, PhD No disclosure on file
Irene L. Katzan, MD Dr. Katzan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring . The institution of Dr. Katzan has received research support from TEVA Pharmaceuticals.
Timothy J. Ingall, MBBS, PhD Dr. Ingall has nothing to disclose.
Haralabos Zacharatos, MD Dr. Zacharatos has nothing to disclose.
Zahid Choudary, MD No disclosure on file
Isis M. Duran, MD No disclosure on file
John H. Dougherty, MD No disclosure on file
Robert G. Holloway, MD, MPH, FAAN Dr. Holloway has nothing to disclose.
Jeffrey M. Gelfand, MD, MS, FAAN Dr. Gelfand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arialys. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ventyx Bio. An immediate family member of Dr. Gelfand has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache: The Journal of Head and Face Pain. The institution of Dr. Gelfand has received research support from Genentech/Roche. The institution of Dr. Gelfand has received research support from Vigil Neurosciences. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has a non-compensated relationship as a Trial Steering Committee Chairperson and member with Roche / Genentech that is relevant to AAN interests or activities.
Stacy Donlon, MD No disclosure on file
Mark P. Nespeca, MD No disclosure on file
Vivien H. Lee, MD, FAAN Dr. Lee has nothing to disclose.
Dean Sarco, MD No disclosure on file
Stefano Ruggieri No disclosure on file
Bert B. Vargas, MD, FAAN Dr. Vargas has received personal compensation for serving as an employee of Lilly USA. Dr. Vargas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Football League. Dr. Vargas has or had stock in Eli Lilly. An immediate family member of Dr. Vargas has or had stock in Pfizer.Dr. Vargas has received personal compensation in the range of $500-$4,999 for serving as a Unaffiliated Neurotrauma Consultant with National Football League. Dr. Vargas has received personal compensation in the range of $10,000-$49,999 for serving as a Neurotrauma Consultant with National Association for Stock Car Auto Racing.
Yazan Alderazi, MD, MB BCh BAO No disclosure on file
Jamie Pak, BA No disclosure on file
Sandipan Pati, MD Dr. Pati has nothing to disclose.
Ken Uchino, MD Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aboott Laboratories, Inc.. Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACP JOURNAL CLUB. The institution of Dr. Uchino has received research support from NIH.
MingMing Ning, MD No disclosure on file
Jennifer J. Manly, PhD The institution of Dr. Manly has received research support from NIH. Dr. Manly has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with University of Mississippi.
Maria I. Aguilar, MD Dr. Aguilar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech.
Paolo Bellantonio, MD No disclosure on file
Antonio Carolei, MD No disclosure on file
Norman Putzki, MD No disclosure on file
Christian Brandt, MD Dr. Brandt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Brandt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW. Dr. Brandt has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Desitin. Dr. Brandt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arvelle. Dr. Brandt has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Brandt has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Brandt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zogenix. Dr. Brandt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GW. Dr. Brandt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Arvelle. The institution of Dr. Brandt has received research support from Rubin-Stiftung. Dr. Brandt has received publishing royalties from a publication relating to health care.
Anish Kanungo, MD No disclosure on file
Nabila Dahodwala, MD, FAAN Dr. Dahodwala has received personal compensation in the range of $0-$499 for serving as a Consultant for Genentech. Dr. Dahodwala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mediflix. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Post and Schell. Dr. Dahodwala has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for O'Brien & Ryan, LLP. Dr. Dahodwala has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for MotleyRice. The institution of Dr. Dahodwala has received research support from AbbVie. The institution of Dr. Dahodwala has received research support from Medtronic.
Ramon R. Diaz-Arrastia, MD, PhD, FAAN Dr. Diaz-Arrastia has stock in BrainBox, LLC. Dr. Diaz-Arrastia has stock in Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense.
Theodore R. Brown, MD Dr. Brown has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astellas. The institution of Dr. Brown has received research support from Merck.
John M. Olichney, MD No disclosure on file
Rohit Dhall, MD, FAAN Dr. Dhall has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Best Doctors Inc. Dr. Dhall has stock in Verve Therapeutics Inc. Dr. Dhall has stock in Roche Holding Limited. Dr. Dhall has stock in Enliven Therapeutics Inc. The institution of Dr. Dhall has received research support from Amneal. The institution of Dr. Dhall has received research support from Neuroderm. The institution of Dr. Dhall has received research support from Cerevel Therapeutics. The institution of Dr. Dhall has received research support from Neurocrine. The institution of Dr. Dhall has received research support from Neuraly. The institution of Dr. Dhall has received research support from SPARC. The institution of Dr. Dhall has received research support from Pharma2B. The institution of Dr. Dhall has received research support from Alexion. The institution of Dr. Dhall has received research support from Parkinsons Foundation. The institution of Dr. Dhall has received research support from UCB Pharma. The institution of Dr. Dhall has received research support from Inhibikase Therapeutics. The institution of Dr. Dhall has received research support from Amylyx Pharma.
Michelle M. Mezei, MD No disclosure on file
Taha Gholipour, MD Dr. Gholipour has nothing to disclose.
Petr Kanovsky, PhD Dr. Kanovsky has nothing to disclose.
Tamir S. Ben-Hur, MD, PhD The institution of Dr. Ben-Hur has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MAPI Pharma. The institution of Dr. Ben-Hur has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kadimastem. The institution of Dr. Ben-Hur has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sipnose. The institution of Dr. Ben-Hur has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regenera Pharma. The institution of Dr. Ben-Hur has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medasense. Dr. Ben-Hur has received stock or an ownership interest from Sipnose. Dr. Ben-Hur has received stock or an ownership interest from Kadimastem. Dr. Ben-Hur has received stock or an ownership interest from MAPI Pharma. Dr. Ben-Hur has received intellectual property interests from a discovery or technology relating to health care.
Sayona John, MD, FAAN Dr. John has nothing to disclose.
Jennifer Ault, DO, PhD, PT No disclosure on file
Rachel Marie E. Salas, MD, MEd, FAAN Dr. Salas has received personal compensation for serving as an employee of HMPGlobal. Dr. Salas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Learning Network. Dr. Salas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for PRIME. Dr. Salas has received publishing royalties from a publication relating to health care.
Panitha Jindahra, MD No disclosure on file
Michael Weller, MD Dr. Weller has received personal compensation in the range of $0-$499 for serving as a Consultant for Neurosense. Dr. Weller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medac. Dr. Weller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Weller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Philogen. Dr. Weller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Weller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Weller has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Curevac. Dr. Weller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus. Dr. Weller has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novocure. The institution of Dr. Weller has received research support from Versameb.
Supurna Ghosh, PhD Dr. Ghosh has received personal compensation for serving as an employee of Revalesio Corporation.
Lorenzo Pinessi, MD No disclosure on file
Lisa Laing No disclosure on file
David J. Szmulewicz, MD No disclosure on file
Christine S. Wong, MD No disclosure on file
Pierre-Olivier Despault-Duquette No disclosure on file
Jill Miller-Horn, MD Dr. Miller-Horn has nothing to disclose.
Paola De Martino, MD, PhD No disclosure on file
Spozhmy Panezai, MD Dr. Panezai has nothing to disclose.
Kari D. Moore, RN, APRN Ms. Moore has nothing to disclose.
Veronica A. Bruno, MD Dr. Bruno has nothing to disclose.
Danny Estupinan, MD Dr. Estupinan has nothing to disclose.
Daniela Arecco No disclosure on file
Brigid Staley No disclosure on file
Sarah I. Sheikh, BM Bch, MSc, MRCP, FAAN Dr. Sheikh has received personal compensation for serving as an employee of Takeda.
Giuseppe Ribizzi No disclosure on file
Byeong-chae Kim, MD, PhD No disclosure on file
Anne Klein No disclosure on file
Petra Nytrova No disclosure on file
Sebastian F. Ameriso, MD Dr. Ameriso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PHRI. Dr. Ameriso has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer, Boehringer, Abbott, AstraZeneca.
Marc De Backer, MD, FBCPM, MBA No disclosure on file
Justin Daugherty No disclosure on file
Radoslaw Kazmierski, MD, PhD Dr. Kazmierski has nothing to disclose.
Michael Lee, MD No disclosure on file
Paola Tortorella No disclosure on file
Richard Watson, MD No disclosure on file
Saskia Bresch, MD Dr. Bresch has nothing to disclose.
Kirsten Platho-Elwischger No disclosure on file
Isabelle Guilleret, PhD No disclosure on file
Himanshu U. Kaulas, MD No disclosure on file
Joji Kuramatsu, MD No disclosure on file
Francisco Zagmutt No disclosure on file
Krystyna Mitosek-Szewczyk, MD No disclosure on file
Nichole A. Mesnard-Hoaglin, PhD No disclosure on file
Zbigniew Stelmasiak, PhD No disclosure on file
Tal Birnberg Tal Birnberg has received personal compensation for serving as an employee of Neuroderm.
Yahia M. Lodi, MD, FAAN Dr. Lodi has nothing to disclose.
Daniel Schneider, MD No disclosure on file
Michael Smith, Exhibito No disclosure on file
Jaspreet Abraham No disclosure on file
James R. Hackney, MD No disclosure on file
Pascal Maisonobe Pascal Maisonobe has received personal compensation for serving as an employee of ipsen pharma. Pascal Maisonobe has received personal compensation for serving as an employee of Ipsen.
Matthew Harms, MD Dr. Harms has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Harms has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Muscular Dystrophy Association. Dr. Harms has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Invitae. Dr. Harms has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Variant Bio. Dr. Harms has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Harms has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. Dr. Harms has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for uniQure. Dr. Harms has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Littlepage Booth. Dr. Harms has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for O'Connor First. Dr. Harms has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Searcy Denney. Dr. Harms has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Ford, Parshall & Baker LLC . The institution of Dr. Harms has received research support from ALS Association. The institution of Dr. Harms has received research support from Ionis. The institution of Dr. Harms has received research support from ALS Finding a Cure. The institution of Dr. Harms has received research support from Target ALS.
Timm Oberwahrenbrock, PhD No disclosure on file
Pedro A. Kowacs, MD, FAAN Dr. Kowacs has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis.
Guido Cavaletti No disclosure on file
Themistokles Kalamatas No disclosure on file
Matthew Macfarlane, MBchB No disclosure on file
Brian T. Wipke, PhD No disclosure on file
Luciana Melamud No disclosure on file
Constance Flamand-Roze No disclosure on file
Koichi Hirata No disclosure on file
David Vaillancourt David Vaillancourt has received personal compensation for serving as an employee of Automated Imaging Diagnostics. David Vaillancourt has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. The institution of David Vaillancourt has received research support from NIH. David Vaillancourt has received intellectual property interests from a discovery or technology relating to health care.
Jinchen Yang, PhD No disclosure on file
Mehmet Yucel, MD No disclosure on file
Haresh Visweshwar No disclosure on file
Tatyana Zhuravleva No disclosure on file
Roberta Grasso No disclosure on file
Robert H. Scannevin, PhD No disclosure on file
Stephanie Taylor No disclosure on file
Solomon L. Moshe, MD, FAAN Dr. Moshe has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink. Dr. Moshe has received publishing royalties from a publication relating to health care. Dr. Moshe has received personal compensation in the range of $500-$4,999 for serving as a Reviewer of study sections with NINDS.
Jan Nolta, PhD No disclosure on file
Erik Wallstroem, MD, PhD Dr. Wallstroem has received personal compensation for serving as an employee of Sanofi. Dr. Wallstroem has stock in Sanofi. Dr. Wallstroem has received intellectual property interests from a discovery or technology relating to health care.
Larry Hansen No disclosure on file
Hakan Akgun No disclosure on file
Alissa Chackerian, PhD No disclosure on file
Hrachya Nersesyan, MD, PhD The institution of an immediate family member of Dr. Nersesyan has received research support from CHA/OSF HealthCare.
Sigal Melamed-Gal No disclosure on file
Ratna K. Bitra, MD No disclosure on file
James Rubenstein No disclosure on file
Samuel J. Potolicchio, Jr., MD No disclosure on file
Samaria Cruz, MD No disclosure on file
Jason P. Mendoza, PhD Dr. Mendoza has received personal compensation for serving as an employee of Biogen. Dr. Mendoza has stock in Biogen.
Joshua Milber No disclosure on file
Dana Swenson-Dravis, MA No disclosure on file
Wei-Qiao Liu, MD No disclosure on file
Murat Yildiz, MD No disclosure on file
Faria S. Amjad, MD Dr. Amjad has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Amjad has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. An immediate family member of Dr. Amjad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myer Squibb. Dr. Amjad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Genentech. Dr. Amjad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Piramal.
Chinwe Nwadiogbu No disclosure on file
Michael L. Reed, PhD The institution of Dr. Reed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Reed has received research support from Allergan. The institution of Dr. Reed has received research support from Dr Reddy's Labs/Promius. The institution of Dr. Reed has received research support from Allay Lamp. Dr. Reed has a non-compensated relationship as a Research Analyst with National Headache Foundation that is relevant to AAN interests or activities.
Konark Malhotra, MD Dr. Malhotra has nothing to disclose.
Styliani (. Marousi No disclosure on file
John F. De Groot, MD An immediate family member of Dr. De Groot has received personal compensation for serving as an employee of Ziopharm Oncology. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Celldex. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Deciphera Pharmaceuticals. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for FivePrime Therapeutics, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GW Pharma. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Carthera. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kadmon. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Biomedical Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Taiho Pharmaceuticals. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kairos Venture Investments. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Syneos Health. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Monteris. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Agios. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mundipharma Research. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GenomiCare. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Blue Earth Diagnostics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Del Mar Pharmaceuticals. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Insightec. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Voyager Therapeutics, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck & Co.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tocagen. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bioasis Technologies, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ResTORbio, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celldex. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Foundation Medicine, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novogen. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Deciphera. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Insys Therapeutics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck & Co.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lily. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novella Clinical. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Karyopharm Therapeutics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Blue Earth Diagnostics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kiyatec. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vanquish Oncology. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orsenix, Insightec. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prelude Therapeutics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Debiopharm Therapeutics, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Global Services, LLC. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VBL Therapeutics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novella. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VBI Vaccines, Inc.. An immediate family member of Dr. De Groot has received stock or an ownership interest from Ziopharm Oncology. An immediate family member of Dr. De Groot has received stock or an ownership interest from Gilead. The institution of Dr. De Groot has received research support from Carthera. The institution of Dr. De Groot has received research support from HaiHe Pharma. The institution of Dr. De Groot has received research support from Taiho Pharma.
Patrick McNamara, PhD No disclosure on file
Daniel Friedman, MD, FAAN The institution of Dr. Friedman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Epilepsy Study Consortium (non-profit). Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Meili Technology. Dr. Friedman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Friedman has stock in Neuroview Technology. The institution of Dr. Friedman has received research support from NIH. The institution of Dr. Friedman has received research support from CDC. The institution of Dr. Friedman has received research support from Epitel. The institution of Dr. Friedman has received research support from Neuropace. The institution of Dr. Friedman has received research support from Rapport Therapeutics. Dr. Friedman has received intellectual property interests from a discovery or technology relating to health care. Dr. Friedman has received intellectual property interests from a discovery or technology relating to health care. Dr. Friedman has received publishing royalties from a publication relating to health care. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Speaker Honorarium with SK Life Sciences. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Speaker Honorarium with AAN. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Travel Reimbursement with Epilepsy Foundation of America.
Katherine McDonell, MD The institution of Dr. McDonell has received research support from NINDS.
Karen Sundell Karen Sundell has received personal compensation for serving as an employee of Acumen Pharmaceuticals . Karen Sundell has stock in Acumen Pharmaceuticals .
Glenn A. Phillips, PhD Dr. Phillips has received personal compensation for serving as an employee of argenx. Dr. Phillips has stock in argenx.
Lei Xu, MD No disclosure on file
Vivienne Shen Vivienne Shen has received personal compensation for serving as an employee of Lundbeck.
Rajat Dhar, MD Dr. Dhar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mid-America Transplant. Dr. Dhar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB Pharma. The institution of Dr. Dhar has received research support from NINDS.
Pietro Cortelli, MD, FAAN Dr. Cortelli has nothing to disclose.
Robert Stern, PhD Robert Stern, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Robert Stern, PhD has received research support from Eisai. The institution of Robert Stern, PhD has received research support from Lilly. The institution of Robert Stern, PhD has received research support from ATRI/NIA. Robert Stern, PhD has received publishing royalties from a publication relating to health care. Robert Stern, PhD has a non-compensated relationship as a Member with NFLPA Mackey-White Committee that is relevant to AAN interests or activities.
Alan M. Rapoport, MD, FAAN Dr. Rapoport has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie, Amgen, Biohaven, Cala Health, Satsuma, Teva Pharmaceutical Industries, Theranica, Xoc and Zosano. Dr. Rapoport has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Amgen, Biohaven, Lundbeck and Teva Pharmaceutical Industries. Dr. Rapoport has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Reviews.
Alan Ettinger, MD, FAAN No disclosure on file
Paula Trzepacz, MD No disclosure on file
Christian Wolf, MD The institution of Dr. Wolf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alphasights Ltd. The institution of Dr. Wolf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Barinthus Biotherapeutics. The institution of Dr. Wolf has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Hoffmann-LaRoche AG. The institution of Dr. Wolf has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunic AG. The institution of Dr. Wolf has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Merck KGaG. Dr. Wolf has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Lycalis. Dr. Wolf has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Viatris.
Erika S. Roers No disclosure on file
Mark T. Brown, MD Dr. Brown has received personal compensation for serving as an employee of Pfizer Inc. Dr. Brown has received stock or an ownership interest from Pfizer Inc.
Jean-Michel Gracies, MD No disclosure on file
Yusei Miyazaki, MD, PhD No disclosure on file
Jack J. Lin, MD Dr. Lin has received stock or an ownership interest from StimScience. Dr. Lin has received stock or an ownership interest from IFovea.
Richard Stark, MBBS, FRACP Dr. Stark has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Stark has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Stark has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Stark has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Stark has stock in CSL. Dr. Stark has stock in Multiple ASX listed (non-medical) companies. Dr. Stark has received personal compensation in the range of $10,000-$49,999 for serving as a TCMC Committee chair with AMA Victoria.
Hugo Javier Aparicio, MD, MPH Dr. Aparicio has received research support from 好色先生. Dr. Aparicio has received research support from Alzheimer's Association. Dr. Aparicio has received research support from National Institutes of Health. Dr. Aparicio has received personal compensation in the range of $10,000-$49,999 for serving as a expert panelist for the Memory & Healthy Aging Program with Cedars-Sinai.
Amparo Gutierrez, MD, FAAN Dr. Gutierrez has nothing to disclose.
Rozalina Dimitrova, MD, MPH No disclosure on file
Thyagarajan Subramanian, MD, MBBS, FAAN Dr. Subramanian has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine. Dr. Subramanian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. Dr. Subramanian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Subramanian has received research support from National Institutes of Health. The institution of Dr. Subramanian has received research support from Ann and Phillip Gladfetler III Foundation. The institution of Dr. Subramanian has received research support from Department of Defense . Dr. Subramanian has received publishing royalties from a publication relating to health care. Dr. Subramanian has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with National Institutes of Health.
James Marriott, MD, MSc Dr. Marriott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Marriott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Marriott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Marriott has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Marriott has received research support from Sanofi. The institution of Dr. Marriott has received research support from Roche. The institution of Dr. Marriott has received research support from Novartis.
Crystal Watson Ms. Watson has received personal compensation for serving as an employee of Atara Biotherapeutics. Ms. Watson has received stock or an ownership interest from Atara Biotherapeutics.
Elisabeth Degenhardt No disclosure on file
Lawrence W. Elmer, MD, PhD Dr. Elmer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acadia Pharmaceuticals. Dr. Elmer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda Therapeutics. Dr. Elmer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal Pharmaceuticals. Dr. Elmer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva Pharmaceuticals. The institution of Dr. Elmer has received research support from Vaccinex, Inc.. The institution of Dr. Elmer has received research support from Cynapsus Therapeutics, Inc.. The institution of Dr. Elmer has received research support from Lundbeck Pharmaceuticals, Inc.. The institution of Dr. Elmer has received research support from Intec Pharmaceuticals, Inc.. The institution of Dr. Elmer has received research support from Pharma Two B. The institution of Dr. Elmer has received research support from Acadia Pharmaceuticals, Inc.. The institution of Dr. Elmer has received research support from Impax Laboratories, LLC. The institution of Dr. Elmer has received research support from Prilenia Therapeutics. The institution of Dr. Elmer has received research support from Neuraly, Inc..
Shannon Kolind, PhD, MSc, BSc Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kolind has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Kolind has received research support from Sanofi Genzyme. The institution of Dr. Kolind has received research support from Roche. The institution of Dr. Kolind has received research support from Biogen.
Ellen Snyder, MD Dr. Snyder has nothing to disclose.
Annie Clark No disclosure on file
Kory Schuh Kory Schuh has received personal compensation for serving as an employee of Eli Lilly and Company.
Giuseppe Salemi, MD No disclosure on file
Maria Rosario Luquin Piudo, MD No disclosure on file
Kersi J. Bharucha, MD No disclosure on file
Bharti Manwani, MD Dr. Manwani has nothing to disclose.
Uyen P. Nguyen No disclosure on file
Victor Otcheretko No disclosure on file
Beatrice Pignolet Beatrice Pignolet has nothing to disclose.
Lynn Liu, MD, FAAN Dr. Liu has nothing to disclose.
Roger Barker, PhD Roger Barker, PhD has nothing to disclose.
Minerva Lopez Ruiz, MD Dr. Lopez Ruiz has nothing to disclose.
Krai Chatamra, PhD No disclosure on file
Joanna Suski, MD Dr. Suski has nothing to disclose.
Christina M. Burch, MD, FAAN Dr. Burch has nothing to disclose.
Sheryl R. Haut, MD Dr. Haut has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Haut has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Haut has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ventus. Dr. Haut has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbieVe. Dr. Haut has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Iqvia.
Richard C. Curry, MD No disclosure on file
Yuki Hatanaka, MD No disclosure on file
David L. Bachman, MD No disclosure on file
Maria del Pilar Guillermo Prieto Eibl, MD Dr. Guillermo Prieto Eibl has nothing to disclose.
Aradhana Mehta No disclosure on file
Aaron McMurtray, MD, FAAN The institution of an immediate family member of Dr. McMurtray has received research support from US Government . An immediate family member of Dr. McMurtray has received intellectual property interests from a discovery or technology relating to health care. Dr. McMurtray has received personal compensation in the range of $100,000-$499,999 for serving as a Panel member with Legal Firm.
Sandra Dewar, PhD, RN, FAES, FAAN, FAAN No disclosure on file
Chutima Saipetch, MD No disclosure on file
Perry Shieh, MD, PhD, FAAN Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Grifols. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Shieh has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Catalyst.
Hardik R. Doshi, MD Dr. Doshi has nothing to disclose.
Saunder Bernes, MD Dr. Bernes has nothing to disclose.
Vivay Peter Misra, MD No disclosure on file
Denise D. Correa, PhD No disclosure on file
Neil B. Billeaud, MD No disclosure on file
Andre P. Matta, MD Dr. Matta has received personal compensation for serving as an employee of Sanofi. Dr. Matta has received stock or an ownership interest from Sanofi.
Janki K. Lavingia, MD No disclosure on file
Wei Hu, MD, PhD No disclosure on file
Ye V. Liang, MD Dr. Liang has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie.
Jayandra Himali Jayandra Himali has nothing to disclose.
Priya Dhawan, MD Dr. Dhawan has nothing to disclose.
Noah A. Kolb, MD Dr. Kolb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abalone Medical. Dr. Kolb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Disarm Therapeutics. Dr. Kolb has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisana corporation. Dr. Kolb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Kolb has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NINDS. Dr. Kolb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kolb has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Locks Law. Dr. Kolb has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for walk up law office . Dr. Kolb has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for ralston, pope, diehl. The institution of Dr. Kolb has received research support from National Cancer Institute.
Augusto Grinspan, MD Dr. Grinspan has received personal compensation for serving as an employee of Insightec.
Avinash Chandra, MD Dr. Chandra has nothing to disclose.
Pedro Rosa Neto, MD, PhD Dr. Rosa Neto has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk.
Jinny O. Tavee, MD Dr. Tavee has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Tavee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Tavee has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. The institution of Dr. Tavee has received research support from Woolsey. The institution of Dr. Tavee has received research support from Milken Foundation. The institution of Dr. Tavee has received research support from CSL Behring. Dr. Tavee has received personal compensation in the range of $0-$499 for serving as a Article author with Medlink.
John Donnelly No disclosure on file
Joseph Duffy The institution of Joseph Duffy has received research support from NIH. Joseph Duffy has received publishing royalties from a publication relating to health care.
Kanika Arora, MD No disclosure on file
Meeta Wagle Cardon, MD Dr. Wagle Cardon has nothing to disclose.
Hassanain Toma, MD No disclosure on file
Ritvij Bowry, MD Dr. Bowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca.
Cecilia Vidal, MD No disclosure on file
Tanya J. McDonald, MD, PhD No disclosure on file
Haseeb A. Rahman, MD Dr. Rahman has nothing to disclose.
Sheridan Reed No disclosure on file
Khondoker Alam, MD No disclosure on file
Janhavi M. Modak, MD No disclosure on file
Atchayaram Nalini, MBBS No disclosure on file
James G. Yarger, CEO No disclosure on file
Ina Teron, MD No disclosure on file
Advait Mahulikar, MD No disclosure on file
A Ingela M Nilsson Remahl, MD No disclosure on file
Rabih Kashouty, MD No disclosure on file
Richa Tripathi, MD Dr. Tripathi has nothing to disclose.
Javier Jose Mallada No disclosure on file
Fernando F. Figueira, MD No disclosure on file
Emily Donovan No disclosure on file
Melanie L. Beaulieu, PhD No disclosure on file
Naira Goukasian No disclosure on file
Maria Elena Cordoba Mosqueda No disclosure on file
Minsoo Kim, MD No disclosure on file
Eugenia Marzo No disclosure on file
Jannatul Ferdous, MD Dr. Ferdous has nothing to disclose.
Jayson D. Rodriguez, MD No disclosure on file
Melissa A. Fellman, MD Dr. Fellman has nothing to disclose.
Victoria Levasseur, MD No disclosure on file
Ying Wu No disclosure on file
Christine B. Rizk, MD Dr. Rizk has stock in BOC Ventures XIX, LP (Gecko RObotics). Dr. Rizk has stock in BOC Ventures XXII, LP (x.AI).
Gabrielle K. Salmers, MD, MBBS No disclosure on file
Greg Gilmet No disclosure on file
Dejan Jakimovski, MD, PhD Dr. Jakimovski has nothing to disclose.
Xiaolan Ye, PhD No disclosure on file
Razina Aziz-Bose, MD Dr. Aziz-Bose has nothing to disclose.
William Mack William Mack has received personal compensation for serving as an employee of NFL. William Mack has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Imperative Care. The institution of William Mack has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vanderbilt University (Stryker study) . William Mack has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ. William Mack has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Goza and Honnald LLC. William Mack has stock in egret therapeutics. William Mack has stock in Borvo. William Mack has stock in Radical Catheters. William Mack has stock in Vastrax. William Mack has stock in Q'Apel. William Mack has stock in Viseon. William Mack has stock in Stream Biomedical. William Mack has stock in Spartan Micro. William Mack has stock in Endostream. The institution of William Mack has received research support from National Institutes of Health.
Inna Keselman, MD, PhD Dr. Keselman has nothing to disclose.
Sanchea M. Wasyliw, MD No disclosure on file
Morad Nasseri, MD No disclosure on file
Edward Greene No disclosure on file
Raja S. Boddepalli, MD No disclosure on file
Nisha Sinha, MD No disclosure on file
Jessie Oldham No disclosure on file
Govind Nair No disclosure on file
Matthew Harris Matthew Harris has nothing to disclose.
Douglas Feltner No disclosure on file
Omar Saeed, MD Dr. Saeed has nothing to disclose.
Daniella Miller, MD Dr. Miller has nothing to disclose.
Muhammad Ubaid Hafeez, MD Dr. Hafeez has nothing to disclose.
Steven H. Nye, PhD No disclosure on file
Tanzi Patricia No disclosure on file
Francisco Barrero No disclosure on file
Stephanie Tankou, MD, PhD No disclosure on file
Sunhee Kim, MD No disclosure on file
Laura Donovan, MD Dr. Donovan has nothing to disclose.
Lars Komorowski Lars Komorowski has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for EUROIMMUN . Lars Komorowski has stock in Revvity. Lars Komorowski has received intellectual property interests from a discovery or technology relating to health care.
Michelle Whaley No disclosure on file
Lauren P. Miller, NP No disclosure on file
Nadav Bleich Kimelman Nadav Bleich Kimelman has nothing to disclose.
Anne Nguyen No disclosure on file
Ihtesham Qureshi, MD No disclosure on file
Joana C. Dias, MD No disclosure on file
Ninad Desai, MBBS Dr. Desai has nothing to disclose.
Heather Clark The institution of Heather Clark has received research support from NIH. Heather Clark has received publishing royalties from a publication relating to health care.